Form 8-K
8-K — Runway Growth Finance Corp.
Accession: 0001104659-26-068282
Filed: 2026-05-29
Period: 2026-05-27
CIK: 0001653384
Item: Entry into a Material Definitive Agreement
Item: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item: Financial Statements and Exhibits
Documents
8-K — tm2616014d1_8k.htm (Primary)
EX-1.1 — EXHIBIT 1.1 (tm2616014d1_ex1-1.htm)
EX-4.2 — EXHIBIT 4.2 (tm2616014d1_ex4-2.htm)
EX-5.1 — EXHIBIT 5.1 (tm2616014d1_ex5-1.htm)
GRAPHIC (tm2616014d1_ex5-1img001.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K — FORM 8-K
8-K (Primary)
Filename: tm2616014d1_8k.htm · Sequence: 1
false
0001653384
0001653384
2026-05-27
2026-05-27
0001653384
rway:CommonStockParValue0.01PerShareMember
2026-05-27
2026-05-27
0001653384
rway:Sec7.50NotesDue2027Member
2026-05-27
2026-05-27
0001653384
rway:Notes7.25Due2031Member
2026-05-27
2026-05-27
0001653384
rway:Notes9.00Due2027Member
2026-05-27
2026-05-27
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 27, 2026
Runway Growth Finance Corp.
(Exact name of Registrant as Specified in Its
Charter)
Maryland
814-01180
47-5049745
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
205 N. Michigan Ave.
Suite 4200
Chicago, Illinois
60601
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including
Area Code: (312) 698-6902
Not Applicable
(Former Name or Former Address,
if Changed Since Last Report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered
pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
RWAY
Nasdaq Global Select Market
7.50% Notes due 2027
RWAYL
Nasdaq Global Select Market
7.25% Notes due 2031
RWAYI
Nasdaq Global Select Market
9.00% Notes due 2027
SWKHL
Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§
230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
Item 1.01. Entry into a Material Definitive Agreement.
On May 27, 2026, Runway Growth Finance Corp.
(the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”)
by and among the Company, Runway Growth Capital LLC and Oppenheimer & Co. Inc., as representative of the underwriters named therein,
in connection with the issuance and sale of $50,000,000 aggregate principal amount of the Company’s 7.00% Notes due 2029 (the “Notes”).
Additionally, on May 29, 2026, the Company
and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), entered into the Fourth Supplemental
Indenture (the “Fourth Supplemental Indenture”) to the Base Indenture, dated July 28, 2022, between the
Company and the Trustee (together with the Fourth Supplemental Indenture, the “Indenture”). The Fourth Supplemental
Indenture relates to the Company’s issuance, offering and sale of
Notes.
The Notes will mature on December 1, 2029,
unless previously redeemed or repurchased in accordance with their terms. The interest rate of the Notes is 7.00% per year and will be
paid semi-annually on June 1 and December 1, commencing December 1, 2026. The Notes are the Company’s direct unsecured
obligations and rank pari passu with the Company’s existing and future unsecured, unsubordinated indebtedness, including
the Company’s 7.50% Notes due 2027, 9.00% Senior Notes due 2027, the 7.51% Series 2025A Senior Notes due 2028 and the 7.25%
Notes due 2031; senior to any
series of preferred stock that it may issue in the future; senior to any
of the Company’s future indebtedness that expressly provides it is subordinated to the Notes; effectively
subordinated to all of the Company’s existing and future secured indebtedness (including indebtedness that is initially unsecured
to which the Company subsequently grants security), to the extent of the value of the assets securing such indebtedness, including, without
limitation, borrowings under the Company’s Credit Agreement with KeyBank National Association (the “Credit Facility”);
and structurally subordinated to all existing and future indebtedness and other obligations of any of the Company’s existing or
future subsidiaries, financing vehicles or similar facilities, including the Credit Facility.
The Notes may be redeemed in whole or in part
at any time or from time to time at the Company’s option
prior to
June 1, 2029
(the “Par Call Date”)
at a redemption price (expressed as a percentage
of the principal amount and rounded to three decimal places) equal to the greater of: (1)(a) the sum of the present values of the
remaining scheduled payments of principal and interest thereon discounted to the redemption date on a semi-annual basis at the Treasury
Rate plus 50 basis points less (b) interest accrued to the date of redemption, and (2) 100% of the principal amount of the Notes
to be redeemed, plus, in either case, accrued and unpaid interest thereon to, but not including, the redemption date.
On or after the Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at a redemption
price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest.
In addition, upon the occurrence of a “change
of control repurchase event”
(as defined in the
Fourth Supplemental
Indenture) prior to the maturity of the Notes, unless the Company has exercised its right to redeem the Notes in full,
holders will have the right, at their option, to require the Company to repurchase for cash some or all of the Notes at
a repurchase price equal to 100% of the principal amount of the Notes being repurchased, plus accrued and unpaid
interest to, but not including, the repurchase date.
The Indenture contains certain covenants, including
covenants requiring the Company to comply with Section 18(a)(1)(A) as modified by Section 61(a)(2) of the Investment
Company Act of 1940, as amended (the “1940 Act”), or any successor provisions
to comply with Section 18(a)(1)(B) as modified by Section 61(a)(2) of the 1940 Act, or any successor provisions,
whether or not the Company continues to be subject to such provisions of the 1940 Act, but giving effect,
in either case, to any exemptive relief granted to the
Company by the Securities and Exchange Commission (the
“SEC”) and certain other exceptions,
and to provide financial information
to the holders of the Notes and the Trustee if the Company should no longer be subject to the
reporting requirements under the Securities
Exchange Act of 1934, as amended.
These covenants are subject to important limitations and exceptions that are set forth in the Indenture.
The Notes were offered and sold in an offering
registered under the Securities Act of 1933, as amended, pursuant to the Company’s registration statement on Form N-2 (Registration
No. 333-284781) previously filed with the SEC, as supplemented by a free writing prospectus dated
May 27, 2026 and a final prospectus supplement dated May 27, 2026. This Current Report on Form 8-K shall not constitute
an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or
jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities
laws of any such state or other jurisdiction. The transaction closed on May 29, 2026.
The Company intends to use the net proceeds from
this offering (a) to repay outstanding indebtedness under the Company’s Credit Facility, and (b) for other general corporate
purposes.
The foregoing descriptions of the Fourth Supplemental
Indenture and the Notes do not purport to be complete and are qualified in their entirety by reference to the full text of the Underwriting
Agreement, the Fourth Supplemental Indenture and the form of global note representing the Notes, respectively, each filed or incorporated
by reference as exhibits hereto and incorporated by reference herein.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation
Under an Off-Balance Sheet Arrangement of a Registrant
The information set forth under Item 1.01 of this Form 8-K is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
Exhibit
Number
Description
1.1
Underwriting Agreement, dated as of May 27, 2026, by and among Runway Growth Finance Corp., Runway Growth Capital LLC and Oppenheimer & Co. Inc.
4.1
Indenture, dated July 28, 2022, by and between Runway Growth Finance Corp. and U.S. Bank Trust Company, National Association, as trustee (Incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on July 28, 2022).
4.2
Fourth Supplemental Indenture, dated May 29, 2026, between Runway Growth Finance Corp. and U.S. Bank Trust Company, National Association, as trustee.
4.3
Form of Global Note (included in Exhibit 4.2 hereto)
5.1
Opinion of Dechert LLP
23.1
Consent of Dechert LLP (included in Exhibit 5.1 hereto)
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: May 29, 2026
RUNWAY GROWTH FINANCE CORP.
By:
/s/ Thomas B. Raterman
Thomas B. Raterman
Chief Operating Officer, Chief Financial Officer, Treasurer and Secretary
EX-1.1 — EXHIBIT 1.1
EX-1.1
Filename: tm2616014d1_ex1-1.htm · Sequence: 2
Exhibit 1.1
Execution Version
RUNWAY GROWTH FINANCE CORP.
(a Maryland corporation)
$50,000,000
7.00% Notes due 2029
UNDERWRITING AGREEMENT
Dated: May 27, 2026
May 27, 2026
Oppenheimer & Co. Inc.
85 Broad Street, 23rd Floor
New York, New York 10004
as Representative of the
several Underwriters named
in Schedule I hereto
Ladies and Gentlemen:
Runway Growth Finance Corp.,
a Maryland corporation (the “Company”), proposes to issue and sell to the Underwriters named in Schedule I
hereto (the “Underwriters”), for whom Oppenheimer & Co. Inc. is acting as representative (in such capacity,
the “Representative”), $50,000,000 aggregate principal amount of 7.00% Notes due 2029 (the “Notes”).
The Notes are hereinafter
referred to as the “Securities.” The Securities will be issued under an indenture dated as of July 28, 2022 (the
“Base Indenture”), as supplemented by the Fourth Supplemental Indenture dated as of May 29, 2026 (the “Fourth
Supplemental Indenture” and, together with the Base Indenture, the “Indenture”) between the Company and
U.S. Bank Trust Company, National Association, as trustee (the “Trustee”). The Securities will be issued to Cede &
Co. as nominee of the Depository Trust Company (“DTC”), pursuant to a blanket letter of representations dated as of
July 18, 2022 (the “DTC Agreement”) between the Company and DTC.
The Company has filed pursuant
to the Securities Act of 1933, as amended (collectively with the rules and regulations of the Commission promulgated thereunder,
the “Securities Act”), with the U.S. Securities and Exchange Commission (the “Commission”) a shelf
registration statement on Form N-2 (File No. 333-284781), which registered the offer and sale of certain securities to be issued
from time to time by the Company, including the Notes. Such registration statement was declared effective by the Commission on March 19,
2025. The registration statement as amended as of its most recent effective date, including the exhibits and schedules thereto, all documents
incorporated or deemed to be incorporated in the registration statement by reference, any information contained in a prospectus supplement
relating to the Securities subsequently filed with the Commission pursuant to Rule 424 under the Securities Act (“Rule 424”)
and deemed to be a part of the registration statement at the time of effectiveness pursuant to Rule 430B under the Securities Act
(“Rule 430B”), any registration statement filed pursuant to Rule 462(b) under the Securities Act (“Rule 462(b)”),
and any post-effective amendment thereto, is hereinafter referred to as the “Registration Statement.”
The base prospectus included
in the Registration Statement as of its most recent effective date, including documents incorporated or deemed to be incorporated therein
by reference, is hereinafter referred to as the “Base Prospectus.” The Company will file with the Commission, in accordance
with Rule 424, a final prospectus supplement, including documents incorporated or deemed to be incorporated therein by reference
(the “Final Prospectus Supplement”), supplementing the Base Prospectus in connection with the offer and sale of the
Notes. The Base Prospectus and the Final Prospectus Supplement are hereinafter referred to collectively as the “Prospectus.”
Any reference herein to the Registration Statement, the Base Prospectus, the Final Prospectus Supplement or the Prospectus shall be deemed
to refer to and include any supplements or amendments thereto, filed with the Commission after the date of filing of the Prospectus under
Rule 424 and prior to the termination of the offering of the Notes by the Representative. All references in this Agreement to financial
statements and schedules and other information which is “included” or “stated” in the Registration Statement
or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules
and other information which is or is deemed to be incorporated in or otherwise deemed to be a part of or included in the Registration
Statement or the Prospectus, as the case may be, as of any specified date; and all references in this Agreement to amendments or supplements
to the Registration Statement or the Prospectus, including those made pursuant to Rule 424 or such other rule under the Securities
Act as may be applicable to the Company, shall be deemed to mean and include, without limitation, the filing of any document under the
Securities Exchange Act of 1934, as amended (the “Exchange Act”) which is or is deemed to be incorporated by reference
in the Registration Statement or the Prospectus, as the case may be, as of any specified date.
The Company has entered into
the Third Amended and Restated Investment Advisory Agreement, dated as of January 30, 2025 (the “Investment Advisory Agreement”),
with Runway Growth Capital LLC, a Delaware limited liability company registered as an investment adviser (the “Adviser”)
under the Investment Advisers Act of 1940, as amended, and the rules and regulations thereunder (the “Advisers Act”).
The Company has also entered
into the Amended and Restated Administration Agreement, dated as of June 28, 2021 (the “Administration Agreement”),
with Runway Administrator Services LLC, a Delaware limited liability company (the “Administrator”).
As used in this Agreement:
“Applicable
Time” means 4:00 P.M., New York City time, on May 27, 2026, or such other time as agreed by the Company and the Representative.
“General
Disclosure Package” means (i) the Base Prospectus, and (ii) the information included on Schedule II hereto.
1. Representations and Warranties.
(a) Representations
and Warranties of the Company. The Company represents and warrants to each Underwriter as of the date hereof, the Applicable Time,
and the Closing Date (as defined below), and agrees with each Underwriter, as follows:
(i) The
Registration Statement has become effective, no stop order suspending the effectiveness of the Registration Statement is in effect, and
no proceedings for such purpose are pending before or, to the knowledge of the Company, threatened by the Commission.
(ii) The
Company is eligible to use Form N-2. In addition, (A) the Registration Statement, when it most recently became effective, did
not contain and, as amended or supplemented, if applicable, will not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the statements therein not misleading, (B) the Registration Statement,
General Disclosure Package and the Prospectus comply and, as amended or supplemented, if applicable, will comply in all material respects
with the Securities Act and the applicable rules and regulations of the Commission promulgated thereunder, (C) the General
Disclosure Package does not, and, at the time of sale of the Securities in connection with the offering when the Prospectus is not yet
available to prospective purchasers and at the Closing Date (as defined below), the General Disclosure Package, as then amended or supplemented
by the Company, if applicable, will not, contain any untrue statement of a material fact or omit to state a material fact necessary to
make the statements therein, in the light of the circumstances under which they were made, not misleading, (D) each Additional Disclosure
Item (as defined below) listed on Schedule III hereto does not and will not conflict with the information contained in the Registration
Statement or the General Disclosure Package and each such Additional Disclosure Item, as supplemented by and taken together with the
General Disclosure Package as of the Applicable Time, did not and will not include any untrue statement of a material fact or omit to
state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading, and (E) the Prospectus, as of the date thereof, does not contain and, as of the Closing Date (as defined in Section 4
hereof), as amended or supplemented, if applicable, will not contain any untrue statement of a material fact or omit to state a material
fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided,
however, that the representations and warranties in this paragraph shall not apply to statements in or omissions from the Registration
Statement, the General Disclosure Package or the Prospectus, or any amendments or supplements thereto, made in reliance upon and in conformity
with information relating to any Underwriter furnished to the Company in writing by any Underwriter expressly for use in the Registration
Statement, the General Disclosure Package or the Prospectus (the “Underwriter Information”), it being understood and
agreed that the Underwriter Information solely consists of the following information in the Final Prospectus Supplement furnished on
behalf of each Underwriter: (1) the names and corresponding principal amount of Notes set forth in the table after the first paragraph
of text under the caption “Underwriting” in the Prospectus; (2) the fifth paragraph of text under the caption “Underwriting”
in the Prospectus concerning the terms of the offering by the Underwriters; (3) the first and second sentences of the second paragraph
of text under the caption “Underwriting—New Listing of Notes” in the Prospectus; and (4) the text under the caption
“Underwriting—Price Stabilization and Short Positions” in the Prospectus.
3
(iii) Exchange
Act Conformance. The documents incorporated by reference in each of the Registration Statement and the Prospectus, when they became
effective or were filed with the Commission, as the case may be, conformed or will conform in all material respects to the requirements
of the Exchange Act.
(iv) Company
Not Ineligible Issuer. At the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest
time thereafter that the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) under
the Securities Act) of the Securities and at the date hereof, the Company was not and is not an “ineligible issuer,” as defined
in Rule 405 under the Securities Act (“Rule 405”), without taking account of any determination by the Commission
pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible issuer.
(v) Emerging
Growth Company Status. The Company is an “emerging growth company,” as defined in Section 2(a)(19) of the Securities
Act (an “Emerging Growth Company”).
(vi) Independent
Accountants. The accountants who certified the financial statements and supporting schedules included in the Registration Statement,
the General Disclosure Package and the Prospectus are independent public accountants as required by the Securities Act, the Exchange
Act and the Public Company Accounting Oversight Board.
(vii) Financial
Statements. The financial statements included or incorporated by reference in the Registration Statement, the General Disclosure
Package and the Prospectus, together with the related schedules and notes, present fairly in all material respects the financial position
of the Company at the dates indicated and the results of their operations and the changes in the cash flows for the periods specified,
and said financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”)
applied on a consistent basis throughout the periods involved. The supporting schedules included in the Registration Statement, if any,
present fairly in all material respects in accordance with GAAP the information required to be stated therein. No historical or pro forma
financial statements or supporting schedules are required to be included in the Registration Statement, the General Disclosure Package
or the Prospectus under the Securities Act that are not so included.
(viii) No
Material Adverse Change in Business. Since the respective dates as of which information is given in the Registration Statement, the
General Disclosure Package or the Prospectus, except as disclosed in the Registration Statement, the General Disclosure Package or the
Prospectus, (A) there has been no material adverse change in the condition, financial or otherwise, or in the earnings, business
affairs or business prospects of the Company, whether or not arising in the ordinary course of business (a “Material Adverse
Effect”), (B) there have been no transactions entered into by the Company, other than those in the ordinary course of
business, which are material with respect to the Company, and (C) there has been no dividend or distribution of any kind declared,
paid or made by the Company on any class of its capital stock.
(ix) Good
Standing of the Company. The Company has been duly organized and is validly existing as a corporation in good standing under the
laws of the State of Maryland and has corporate power and authority to own, lease and operate its properties and to conduct its business
as described in the Registration Statement, the General Disclosure Package and the Prospectus, to perform its obligations under the Investment
Advisory Agreement and the Administration Agreement, and to enter into and perform its obligations under this Agreement; and the Company
is duly qualified as a foreign corporation to transact business and is in good standing in each other jurisdiction in which such qualification
is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure so to qualify
or to be in good standing would not reasonably be expected to result in a Material Adverse Effect.
4
(x) No
Significant Subsidiaries of the Company; Portfolio Companies. The Company does not own any significant subsidiaries, as defined in
Rule 1-02(w) of Regulation S-X, that are consolidated with the Company for financial reporting purposes under GAAP as of the
date hereof. Except for any investments made in the ordinary course of business since the most recent quarter-end, the Company does not
own, directly or indirectly, any investments or shares of stock or any other equity or long-term debt securities of any corporation or
other entity other than those corporations or other entities described in the Registration Statement, the General Disclosure Package
and the Prospectus (each, a “Portfolio Company” and collectively, the “Portfolio Companies”) as
of the date hereof. Except as otherwise disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, the
Company does not control (as defined in Section 2(a)(9) of the Investment Company Act of 1940, as amended (the “1940
Act”)) any of the Portfolio Companies or any corporation or other entity in which it invested since the most recent quarter-end.
(xi) Capitalization.
The authorized, issued and outstanding shares of capital stock of the Company are as set forth in the Registration Statement, the General
Disclosure Package and the Prospectus in the column entitled “Actual” under the caption “Capitalization.” The
outstanding shares of capital stock of the Company have been duly authorized and validly issued and are fully paid and non-assessable.
None of the outstanding shares of capital stock of the Company were issued in violation of the preemptive or other similar rights of
any securityholder of the Company.
(xii) Authorization
of Agreements. This Agreement, the Investment Advisory Agreement and the Administration Agreement have each been duly authorized,
executed and delivered by the Company. This Agreement, the Investment Advisory Agreement and the Administration Agreement are each valid
and binding obligations of the Company, enforceable against the Company in accordance with their terms, except as the enforcement thereof
may be subject to (A) bankruptcy, insolvency, reorganization, moratorium or other similar laws now or thereafter in effect relating
to creditors’ rights generally and (B) general principles of equity and the discretion of the court before which any proceeding
therefor may be brought.
(xiii) Authorization
of Base Indenture. The Base Indenture has been duly authorized, executed and delivered by the Company and constitutes a valid and
binding obligation of the Company, enforceable against the Company in accordance with its terms, except as the enforcement thereof may
be subject to (A) bankruptcy, insolvency, reorganization, moratorium or other similar laws now or thereafter in effect relating
to creditors’ rights generally and (B) general principles of equity and the discretion of the court before which any proceeding
therefor may be brought.
(xiv) Authorization
of Fourth Supplemental Indenture. The Fourth Supplemental Indenture has been duly authorized by the Company and at the Closing Date
will be executed and delivered by the Company, and when executed and delivered by both of the Company and the Trustee will constitute
a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as the enforcement
thereof may be subject to (A) bankruptcy, insolvency, reorganization, moratorium or other similar laws now or thereafter in effect
relating to creditors’ rights generally and (B) general principles of equity and the discretion of the court before which
any proceeding therefor may be brought.
(xv) Authorization
of DTC Agreement. The DTC Agreement has been duly authorized, executed and delivered by the Company and constitutes a valid and binding
obligation of the Company, enforceable against the Company in accordance with its terms, except as the enforcement thereof may be subject
to (A) bankruptcy, insolvency, reorganization, moratorium or other similar laws now or thereafter in effect relating to creditors’
rights generally and (B) general principles of equity and the discretion of the court before which any proceeding therefor may be
brought.
(xvi) Qualification
of Base Indenture. The Base Indenture has been duly qualified under the Trust Indenture Act of 1939, as amended.
(xvii) Registration
Rights. No person has the right to require the Company to register any securities for sale under the Securities Act by reason of
the filing of the Registration Statement with the Commission or the issuance and sale of the Securities.
5
(xviii) Absence
of Violations, Defaults and Conflicts. The Company is not (A) in violation of its charter or bylaws, each as amended or supplemented
as of the date of this Agreement and the Closing Date, as applicable, (B) in default in the performance or observance of any obligation,
agreement, covenant or condition contained in any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease
or other agreement or instrument to which the Company is a party or by which it may be bound or to which any of the properties or assets
of the Company is subject (collectively, “Agreements and Instruments”), except for such defaults that would not reasonably
be expected, singly or in the aggregate, to result in a Material Adverse Effect, or (C) in violation of any law, statute, rule,
regulation, judgment, order, writ or decree of any arbitrator, court, governmental body, regulatory body, administrative agency or other
authority, body or agency having jurisdiction over the Company or any of its respective properties, assets or operations (each, a “Governmental
Entity”), except for such violations that would not reasonably be expected, singly or in the aggregate, to result in a Material
Adverse Effect. The execution, delivery and performance of this Agreement, the Investment Advisory Agreement, the Administration Agreement,
and the consummation of the transactions contemplated herein and therein and in the Registration Statement, the General Disclosure Package
and the Prospectus (including the issuance and sale of the Securities and the use of the proceeds from the sale of the Securities as
described in the General Disclosure Package and the Prospectus under the caption “Use of Proceeds”) and compliance by the
Company with its obligations hereunder and thereunder have been duly authorized by all necessary corporate action and do not and will
not, whether with or without the giving of notice or passage of time or both, conflict with or constitute a breach of, or default or
Repayment Event (as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any properties
or assets of the Company pursuant to, the Agreements and Instruments (except for such conflicts, breaches, defaults or Repayment Events
or liens, charges or encumbrances that would not reasonably be expected, singly or in the aggregate, to result in a Material Adverse
Effect), nor will such action result in any violation of the provisions of (1) the charter or bylaws of the Company, each as amended
or supplemented as of the date of this Agreement and the Closing Date, as applicable, or (2) any law, statute, rule, regulation,
judgment, order, writ or decree of any Governmental Entity, except, in the case of (2) above, any violation that would not reasonably
be expected, singly or in the aggregate, to result in a Material Adverse Effect. As used herein, a “Repayment Event”
means any event or condition which gives the holder of any note, debenture or other evidence of indebtedness (or any person acting on
such holder’s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by
the Company.
(xix) Employees.
As of the date hereof, the Company does not have, and as of the Closing Date the Company will not have, any employees.
(xx) Absence
of Proceedings. Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, there is no
action, suit, proceeding or, to the knowledge of the Company, inquiry or investigation before or brought by any Governmental Entity now
pending or, to the knowledge of the Company, threatened, against or affecting the Company, which would reasonably be expected to result
in a Material Adverse Effect or which would reasonably be expected to materially and adversely affect the properties or assets of the
Company, the consummation of the transactions contemplated in this Agreement, the Investment Advisory Agreement, or the Administration
Agreement, or the performance by the Company of its obligations hereunder or thereunder; and the aggregate of all pending legal or governmental
proceedings to which the Company is a party or of which any of its properties or assets is the subject which are not described in the
Registration Statement, the General Disclosure Package and the Prospectus, including ordinary routine litigation incidental to the business
of the Company, would not reasonably be expected to result in a Material Adverse Effect.
(xxi) Exchange
Act Compliance. The Company is subject to and in compliance in all material respects with the reporting requirements of Section 13
and Section 15(d) of the Exchange Act, and has timely filed all reports required to be filed pursuant to Sections 13(a) and
15(d) of the Exchange Act during the preceding twelve (12) months.
(xxii) Accuracy
of Exhibits. There are no contracts or documents that are required to be described in the Registration Statement, the General Disclosure
Package or the Prospectus or to be filed as exhibits to the Registration Statement that have not been so described and filed as required.
(xxiii) Absence
of Further Requirements. No filing with, or authorization, approval, consent, license, order, registration, qualification or decree
of, any Governmental Entity is necessary or required for the performance by the Company of its obligations hereunder, in connection with
the offering, issuance or sale of the Securities hereunder, or to effectuate the consummation of the transactions contemplated by this
Agreement, except (A) such as have been already obtained or as may be required under the Securities Act, the 1940 Act, the rules of
the NASDAQ Global Select Market, state securities laws or the rules of the Financial Industry Regulatory Authority, Inc. (“FINRA”)
and (B) where the failure to obtain any such filing, authorization, approval, consent, license, order, registration, qualification
or decree would not reasonably be expected, singly or in the aggregate, to have a Material Adverse Effect.
(xxiv) Possession
of Licenses and Permits. The Company possesses such permits, licenses, approvals, consents and other authorizations (collectively,
“Governmental Licenses”) issued by the appropriate Governmental Entities necessary to conduct the business now operated
by the Company, except where the failure so to possess would not reasonably be expected, singly or in the aggregate, to result in a Material
Adverse Effect. The Company is in compliance with the terms and conditions of all Governmental Licenses, except where the failure so
to comply would not reasonably be expected, singly or in the aggregate, to result in a Material Adverse Effect. All of the Governmental
Licenses are valid and in full force and effect, except when the invalidity of such Governmental Licenses or the failure of such Governmental
Licenses to be in full force and effect would not reasonably be expected, singly or in the aggregate, to result in a Material Adverse
Effect. The Company has not received any notice of proceedings relating to the revocation or modification of any Governmental Licenses
which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to result
in a Material Adverse Effect.
6
(xxv) Title
to Property. The Company does not own any real property. Any leases and subleases material to the business of the Company, and under
which the Company holds properties, if any, are in full force and effect, and the Company has not received any notice of any material
claim of any sort that has been asserted by anyone adverse to the rights of the Company under any of the foregoing leases or subleases,
or affecting or questioning the rights of the Company to the continued possession of the leased or subleased premises under any such
lease or sublease that, singly or in the aggregate, would reasonably be expected to result in a Material Adverse Effect.
(xxvi) Possession
of Intellectual Property. Except as would not reasonably be expected, singly or in the aggregate, to result in a Material Adverse
Effect, the Company owns or possesses, or can acquire on reasonable terms, adequate patents, patent rights, licenses, inventions, copyrights,
know-how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures),
trademarks, service marks, trade names or other intellectual property (collectively, “Intellectual Property”) necessary
to carry on the business now operated by the Company, and the Company has not received any notice or is otherwise aware of any infringement
of or conflict with asserted rights of others with respect to any Intellectual Property or of any facts or circumstances which would
render any Intellectual Property invalid or inadequate to protect the interest of the Company therein, and which infringement or conflict
(if the subject of any unfavorable decision, ruling or finding) or invalidity or inadequacy, singly or in the aggregate, would reasonably
be expected to result in a Material Adverse Effect.
(xxvii) Accounting
Controls. The Company maintains a system of internal control over financial reporting (as defined in Rules 13a-15(f) and
15d-15(f) under the Exchange Act) and a system of internal accounting controls sufficient to provide reasonable assurances that
(A) transactions are executed in accordance with management’s general or specific authorization, (B) transactions are
recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets,
(C) access to the Company’s consolidated assets is permitted only in accordance with management’s general or specific
authorization, and (D) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate
action is taken with respect to any differences. Except as described in the Registration Statement, the General Disclosure Package and
the Prospectus, since the end of the Company’s most recent audited fiscal year, there has been (1) no material weakness in
the Company’s internal control over financial reporting (whether or not remediated) and (2) no change in the Company’s
internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s
internal control over financial reporting (it being understood that the Company is newly required to comply with the auditor attestation
requirements under Section 404(b) of the Sarbanes-Oxley Act of 2002, as amended).
(xxviii) Payment
of Taxes. All United States federal income tax returns of the Company required by law to have been filed by the Company (taking into
account any applicable extensions) have been filed and all taxes shown by such returns or otherwise assessed, which are due and payable,
have been paid, or insofar as the failure to do so would not reasonably be expected, singly or in the aggregate, to result in a Material
Adverse Effect. The United States federal income tax returns of the Company through the fiscal year ended December 31, 2025, have
been filed, and no assessment in connection therewith has been made against the Company. The Company has filed all other tax returns
that are required to have been filed by the Company (taking into account any applicable extensions) pursuant to applicable foreign, state,
local or other law and has paid all taxes due pursuant to such returns or pursuant to any assessment received by the Company, insofar
as the failure to pay such taxes or file such returns would not reasonably be expected to result in a Material Adverse Effect. The charges,
accruals and reserves on the books of the Company in respect of any income and corporation tax liability for any years not finally determined
are adequate to meet any current assessments or re-assessments for additional income tax for any fiscal year not finally determined,
except to the extent of any inadequacy that would not reasonably be expected to result in a Material Adverse Effect.
7
(xxix) Insurance.
The Company carries or is entitled to the benefits of insurance, with financially sound and reputable insurers, in such amounts and covering
such risks as the Company reasonably believes is prudent, and all such insurance is in full force and effect. The Company has no reason
to believe that it will not be able (A) to renew its existing insurance coverage as and when such policies expire or (B) to
obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and
at a cost that would not reasonably be expected to result in a Material Adverse Effect.
(xxx) 1940
Act. The Company is not required, and upon the issuance and sale of the Securities as herein contemplated and the application of
the net proceeds therefrom as described in the Prospectus will not be required, to register as a “management investment company”
under the 1940 Act.
(xxxi) Stabilization
and Manipulation. The Company has not taken nor will it take, directly or indirectly, without giving effect to any activities by
the Underwriters, any action designed, or that would reasonably be expected to cause or result in, or that constitutes, any stabilization
or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities.
(xxxii) No
Unlawful Payments. The Company has not, nor has any director, officer or employee of the Company or, to the knowledge of the Company,
any agent, affiliate or other person associated with or acting on behalf of the Company (i) used any corporate funds for any unlawful
contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) made or taken an act in furtherance
of an offer, payment, promise or authorization of any direct or indirect unlawful payment or benefit to any foreign or domestic government
official or employee, including of any government-owned or controlled entity or of a public international organization, or any person
acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political
office, or any person in violation of any applicable anti-corruption laws; (iii) violated or is in violation of any provision of
the Foreign Corrupt Practices Act of 1977, as amended (the “FCPA”), or any applicable law or regulation implementing
the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence
under the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered,
agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any
rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. The Company has conducted its business
in compliance with applicable anti-corruption laws and has instituted, maintained and enforced, and will continue to maintain and enforce
policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption laws and with
the representations and warranties contained herein, and the Company will not use, directly or indirectly, the proceeds of the offering
of the Securities in furtherance of any payment, promise to pay, or authorization of the payment or giving of money, or anything else
of value, to any person in violation of any applicable anti-corruption laws.
(xxxiii) Compliance
with Anti-Money Laundering Laws. The operations of the Company are and have been conducted at all times in compliance with applicable
financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as
amended by the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)) (the “USA Patriot Act”),
the applicable money laundering statutes of all jurisdictions where the Company conducts business, the rules and regulations thereunder
and any related or similar rules, regulations or guidelines issued, administered or enforced by any Governmental Entity (collectively,
the “Anti-Money Laundering Laws”), and no action, suit or proceeding by or before any Governmental Entity involving
the Company with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.
8
(xxxiv) No
Conflicts with Sanctions Laws. None of the Company or any of its subsidiaries, directors, officers, or employees, or, to the knowledge
of the Company, any agent, affiliate or other person associated with or acting on behalf of the Company, is an individual or entity that
is, or is owned or controlled by one or more individuals or entities that are currently the subject or the target of any economic sanctions
laws, regulations, embargoes or restrictive measures administered, enacted or enforced by the U.S. government, (including, without limitation,
the Office of Foreign Assets Control of the U.S. Department of the Treasury, the U.S. Department of Commerce or the U.S. Department of
State and including, without limitation, the designation as a “specially designated national” or “blocked person”),
the United Nations Security Council, the European Union, His Majesty’s Treasury, or any other relevant sanctions authority (collectively,
“Sanctions”), nor is the Company or any of its subsidiaries, directors, officers, or employees, or, to the knowledge
of the Company, any agent, affiliate, or other person associated with or acting on behalf of the Company, an individual or entity that
is, or is owned or controlled by one or more individuals or entities that are, located, organized or resident in a country or territory
that is the subject or target of comprehensive Sanctions, including, without limitation, as of the date hereof, the Crimea regions of
Ukraine, Cuba, Iran, North Korea, the so-called Donetsk People’s Republic and the so-called Luhansk People’s Republic
(each, a “Sanctioned Jurisdiction”); and the Company will not directly or indirectly use the proceeds of the offering
of the Securities hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or
other individual or entity (A) to fund or facilitate any activities of or business with any individual or entity that, at the time
of such funding or facilitation, is the subject or target of Sanctions, (B) to fund or facilitate any activities of or business
in any Sanctioned Jurisdiction, or (C) in any other manner that will result in a violation by any individual or entity participating
in the transaction, whether as underwriter, advisor, investor or otherwise, of Sanctions. Since its inception, the Company has not knowingly
engaged in, is not now knowingly engaged in, and will not knowingly engage in, any dealings or transactions with any person that at the
time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Jurisdiction.
(xxxv) Lending
Relationship. Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, the Company
(A) does not have any material lending or other relationship with any bank or lending affiliate of any Underwriter and (B) does
not intend to use any of the proceeds from the sale of the Securities to repay any outstanding debt owed to any affiliate of any Underwriter.
(xxxvi) Statistical
and Market-Related Data. Any statistical and market-related data included in the Registration Statement, the General Disclosure Package
or the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate and, to the extent required,
the Company has obtained the written consent to the use of such data from such sources.
(xxxvii) Related
Party Transactions. There are no business relationships or related party transactions involving the Company or any other person required
to be described in the Registration Statement, the General Disclosure Package or the Prospectus which have not been described as required.
(xxxviii) Notification
of Election. When the Company filed its Notification of Election to be subject to Sections 55 through 65 of the 1940 Act on Form N-54A
with the Commission pursuant to Section 54(a) of the 1940 Act, such Form N-54A (A) contained all statements required
to be stated therein in accordance with, and complied in all material respects with the requirements of, the 1940 Act, and (B) did
not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading.
(xxxix) Investment
Advisory Agreement. The Company confirms that (A) the terms of the Investment Advisory Agreement, including compensation terms,
comply in all material respects with all applicable provisions of the 1940 Act and the Advisers Act, and (B) the approvals by the
board of directors and the stockholders of the Company of the Investment Advisory Agreement have been made in accordance with the requirements
of Sections 15(a) and 15(c) of the 1940 Act and the rules and regulations promulgated under the 1940 Act that are applicable
to companies that have elected to be regulated as business development companies under the 1940 Act.
(xl) Interested
Persons. Except as disclosed in the Registration Statement and the Prospectus, (A) no person is serving or acting as an officer,
director or investment adviser of the Company, except in accordance with the provisions of the 1940 Act and the Advisers Act, and (B) to
the knowledge of the Company, no director of the Company is an “interested person” (as defined in the 1940 Act) of the Company
or an “affiliated person” (as defined in the 1940 Act) of any of the Underwriters.
9
(xli) Business
Development Company. The Company has duly elected to be regulated by the Commission under the 1940 Act as a business development
company, such election is effective and all required action has been taken by the Company under the Securities Act and the 1940 Act to
make the public offering and consummate the sale of the Securities as provided in this Agreement, the provisions of the charter and bylaws
of the Company, and the investment objectives, policies and restrictions described in the Prospectus, assuming they are implemented as
described, will comply in all material respects with the requirements of the 1940 Act, and the operations of the Company are in compliance
in all material respects with the provisions of the 1940 Act and the 1940 Act rules and regulations applicable to business development
companies.
(xlii) No
Extension of Credit. The Company has not, directly or indirectly, extended credit, agreed to extend credit, arranged to extend credit
or renewed any extension of credit, in the form of a personal loan, to or for any director or executive officer of the Company, or to
or for any family member or affiliate of any director or executive officer of the Company.
(xliii) Regulated
Investment Company. The Company has elected to be treated and has operated and intends to continue to operate its business in such
a manner as to enable the Company to continue to qualify as a regulated investment company under subchapter M of the Internal Revenue
Code of 1986, as amended (the “Code”). The Company intends to direct the investment of the proceeds of the offering
of the Securities in a manner as to comply with the requirements of subchapter M of the Code.
(xliv) Cybersecurity;
Data Protection. The Company’s information technology assets and equipment, computers, systems, networks, hardware, software,
websites, applications, and databases (collectively, “IT Systems”) are adequate for, and operate and perform in all
material respects as required in connection with, the operation of the business of the Company as currently conducted. The Company has
implemented and maintained commercially reasonable controls, policies, procedures, and safeguards to maintain and protect its material
confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data (including all personal,
personally identifiable, sensitive, confidential or regulated data (“Personal Data”)) used in connection with the
Company’s businesses, and there have been no breaches, violations, outages or unauthorized uses of or accesses to same, except
for those that have been remedied without material cost or liability or the duty to notify any other person, nor are there any incidents
under internal review or investigations relating to the same. The Company is presently in material compliance with all applicable laws
or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority,
internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection
of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification.
(xlv) Distribution
of Offering Materials. The Company has not distributed and will not distribute any offering material in connection with the sale
of the Securities other than the Registration Statement, the Prospectus, the General Disclosure Package and the Additional Disclosure
Items (as defined in Section 6(c)).
(b) Representations
and Warranties by the Adviser. The Adviser represents to each Underwriter as of the date hereof, the Applicable Time, and the Closing
Date (as defined below), and agrees with each Underwriter, as follows:
(i) No
Material Adverse Change in Business. Except as otherwise stated therein, since the respective dates as of which information is given
in the Registration Statement, the General Disclosure Package or the Prospectus, there has been no material adverse change in the condition,
financial or otherwise, or in the earnings, business affairs, business prospects or regulatory status of the Adviser, whether or not
arising in the ordinary course of business, or on the ability of the Adviser or the Administrator to carry out its obligations under
this Agreement, the Investment Advisory Agreement or the Administration Agreement, as applicable (collectively, an “Adviser
Material Adverse Effect”).
(ii) Good
Standing. The Adviser has been duly organized and is validly existing as a limited liability company, in good standing under the
laws of its state of organization and has limited liability company power and authority to own, lease and operate its properties and
to conduct its business as described in the Registration Statement, the General Disclosure Package and the Prospectus and to enter into
and perform its obligations under this Agreement. The Adviser has limited liability company power and authority to perform its obligations
under the Investment Advisory Agreement, and the Adviser is duly qualified as a foreign entity to transact business and is in good standing
in each other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the
conduct of business, except where the failure so to qualify or to be in good standing would not otherwise reasonably be expected to result
in an Adviser Material Adverse Effect.
10
(iii) Registration
Under Advisers Act. The Adviser is duly registered with the Commission as an investment adviser under the Advisers Act and is not
prohibited by the Advisers Act or the 1940 Act from acting under the Investment Advisory Agreement for the Company as contemplated by
the Registration Statement, the General Disclosure Package and the Prospectus. There does not exist any proceeding or, to the Adviser’s
knowledge, any facts or circumstances the existence of which could lead to any proceeding which might adversely affect the registration
of the Adviser with the Commission.
(iv) Absence
of Proceedings. Except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, there is no
action, suit, proceeding or, to the knowledge of the Adviser, inquiry or investigation before or brought by any arbitrator, court, governmental
body, regulatory body, administrative agency or other authority, body or agency having jurisdiction over the Adviser, its subsidiaries
or any of their properties, assets or operations now pending or, to the knowledge of the Adviser, threatened, against or affecting the
Adviser or its subsidiaries, which is required to be disclosed in the Registration Statement (other than disclosed therein) or which
would reasonably be expected to result in an Adviser Material Adverse Effect, or which would reasonably be expected to materially and
adversely affect their properties or assets or the consummation of the transactions contemplated in this Agreement, the Investment Advisory
Agreement or the Administration Agreement or the performance by the Adviser of its obligations hereunder or thereunder; and the aggregate
of all pending legal or governmental proceedings to which the Adviser or any of its subsidiaries is a party or of which any of their
properties or assets is the subject which are not described in the Registration Statement, the General Disclosure Package and the Prospectus,
including ordinary routine litigation incidental to their business, would not reasonably be expected to result in an Adviser Material
Adverse Effect.
(v) Absence
of Violations, Defaults and Conflicts. The Adviser is not (A) in violation of its limited liability company agreement, (B) in
default in the performance or observance of any obligation, agreement, covenant or condition contained in any contract, indenture, mortgage,
deed of trust, loan or credit agreement, note, lease or other agreement or instrument to which the Adviser is a party or by which it
may be bound or to which any of its properties or assets is subject (collectively, the “Adviser Agreements and Instruments”),
except for such defaults that would not reasonably be expected, singly or in the aggregate, to result in an Adviser Material Adverse
Effect, or (C) in violation of any applicable law, statute, rule, regulation, judgment, order, writ or decree of any arbitrator,
court, governmental body, regulatory body, administrative agency or other authority, body or agency having jurisdiction over the Adviser
or any of its properties, assets or operations, except for such violations that would not reasonably be expected, singly or in the aggregate,
to result in an Adviser Material Adverse Effect. The execution, delivery and performance of this Agreement, the Investment Advisory Agreement
and the Administration Agreement by the Adviser or the Administrator and the consummation of the transactions contemplated herein and
therein and in the Registration Statement, the General Disclosure Package and the Prospectus (including the issuance and sale of the
Securities and the use of the proceeds from the sale of the Securities as described therein under the caption “Use of Proceeds”)
and compliance by the Adviser and the Administrator with their obligations hereunder and under the Investment Advisory Agreement and
Administration Agreement do not and will not, whether with or without the giving of notice or passage of time or both, conflict with
or constitute a breach of, or default under, or result in the creation or imposition of any lien, charge or encumbrance upon any properties
or assets of the Adviser or pursuant to the Adviser Agreements and Instruments (except for such conflicts, breaches, defaults, events
or conditions giving the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder’s
behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Adviser, or liens,
charges or encumbrances that would not reasonably be expected, singly or in the aggregate, to result in an Adviser Material Adverse Effect),
nor will such action result in any violation of the provisions of (a) the limited liability company agreement of the Adviser, or
(b) any applicable law, statute, rule, regulation, judgment, order, writ or decree of any arbitrator, court, governmental body,
regulatory body, administrative agency or other authority, body or agency having jurisdiction over the Adviser or any of its properties,
assets or operations except, in the case of (b) above, for any violations that would not reasonably be expected, singly or in the
aggregate, to result in an Adviser Material Adverse Effect.
11
(vi) Authorization
of Agreements. This Agreement, the Investment Advisory Agreement and the Administration Agreement have each been duly authorized,
executed and delivered by the Adviser or the Administrator. This Agreement and the Investment Advisory Agreement are valid and binding
obligations of the Adviser, enforceable against it in accordance with their terms, except as the enforcement thereof may be subject to
(i) bankruptcy, insolvency, reorganization, moratorium or other similar laws now or thereafter in effect relating to creditors’
rights generally and (ii) general principles of equity and the discretion of the court before which any proceeding therefor may
be brought.
(vii) Absence
of Further Requirements. No filing with, or authorization, approval, consent, license, order, registration, qualification or decree
of, any court or governmental authority or agency is necessary or required for the performance by the Adviser of its obligations hereunder,
in connection with the offering, issuance or sale of the Securities hereunder or the consummation of the transactions contemplated by
this Agreement or the Investment Advisory Agreement, except (A) such as have been already obtained or as may be required under the
Securities Act, the 1940 Act, the rules of the NASDAQ Global Select Market, state securities laws or the rules of FINRA and
(B) where the failure to obtain any such filing, authorization, approval, consent, license, order, registration, qualification or
decree would not reasonably be expected, singly or in the aggregate, to result in an Adviser Material Adverse Effect.
(viii) Description
of Adviser. The description of the Adviser contained in the Registration Statement, the General Disclosure Package and the Prospectus
does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
to make the statements therein, in the light of the circumstances under which they were made, not misleading.
(ix) Possession
of Licenses and Permits. The Adviser and its subsidiaries each possess such Governmental Licenses issued by the appropriate federal,
state, local or foreign regulatory agencies or bodies necessary to conduct the business now operated by them, except where the failure
so to possess would not reasonably be expected, singly or in the aggregate, to result in an Adviser Material Adverse Effect. The Adviser
and its subsidiaries are in compliance with the terms and conditions of all such Governmental Licenses, except where the failure so to
comply would not reasonably be expected, singly or in the aggregate, to result in an Adviser Material Adverse Effect. All of the Governmental
Licenses are valid and in full force and effect, except when the invalidity of such Governmental Licenses or the failure of such Governmental
Licenses to be in full force and effect would not reasonably be expected, singly or in the aggregate, to result in an Adviser Material
Adverse Effect. The Adviser and its subsidiaries have not received any notice of proceedings relating to the revocation or modification
of any such Governmental Licenses which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would
reasonably be expected to result in an Adviser Material Adverse Effect.
(x) Stabilization
and Manipulation. The Adviser has not taken, nor will the Adviser take, directly or indirectly, without giving effect to any activities
by the Underwriters, any action designed, or that would reasonably be expected, to cause or result in, or which constitutes, the stabilization
or manipulation of the price of the Securities.
(xi) No
Unlawful Payments. Neither the Adviser nor any of its subsidiaries, nor any director, officer or employee of the Adviser or any of
its subsidiaries nor, to the knowledge of the Adviser, any agent, affiliate or other person associated with or acting on behalf of the
Adviser or any of its subsidiaries has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other
unlawful expense relating to political activity; (ii) made or taken an act in furtherance of an offer, payment, promise or authorization
of any direct or indirect unlawful payment or benefit to any foreign or domestic government official or employee, including of any government-owned
or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any
of the foregoing, or any political party or party official or candidate for political office, or any person in violation of any applicable
anti-corruption laws; (iii) violated or is in violation of any provision of the FCPA or any applicable law or regulation implementing
the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offence
under the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered,
agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any
rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. The Adviser and its subsidiaries have conducted
their business in compliance with applicable anti-corruption laws and have instituted, maintained and enforced, and will continue to
maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption
laws and with the representations and warranties contained herein; and the Adviser and its subsidiaries will not cause the Company to
use, directly or indirectly, the proceeds of the offering of the Securities in furtherance of any payment, promise to pay, or authorization
of the payment or giving of money, or anything else of value, to any person in violation of any applicable anti-corruption laws.
12
(xii) Compliance
with Anti-Money Laundering Laws. The operations of the Adviser and its subsidiaries are and have been conducted at all times in compliance
with applicable financial recordkeeping and reporting requirements of the Anti-Money Laundering Laws, and no action, suit or proceeding
by or before any Governmental Entity or other authority, body or agency having jurisdiction over the Adviser or any of its subsidiaries
or any of their properties, assets or operations involving the Adviser or any of its subsidiaries with respect to the Anti-Money Laundering
Laws is pending or, to the knowledge of the Adviser, threatened.
(xiii) No
Conflicts with Sanctions Laws. Neither the Adviser nor any of its subsidiaries or, to the knowledge of the Adviser, any agent, affiliate
or other person associated with or acting on behalf of the Adviser or any of its subsidiaries is an individual or entity that is, or
is owned or controlled by one or more individuals or entities that are currently the subject or the target of any Sanctions, nor is the
Adviser or any of its subsidiaries located, organized or resident in a Sanctioned Jurisdiction. For the past five years, the Adviser
has not knowingly engaged in, is not now knowingly engaged in, and will not engage in, any dealings or transactions with any person that
at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Jurisdiction.
(xiv) Key
Employees. The Adviser is not aware that (i) any of the executive officers, key employees or significant group of employees
that provide services to the Company pursuant to the Investment Advisory Agreement or Administration Agreement plans to terminate employment
with the Adviser or the Administrator or (ii) any such executive officer or key employee is subject to any noncompete, nondisclosure,
confidentiality, employment, consulting or similar agreement that would be violated by either the Adviser’s present or proposed
business activities, except, in each case, as would not reasonably be expected, singly or in the aggregate, to result in an Adviser Material
Adverse Effect.
(xv) No
Labor Disputes. No labor disturbance by or dispute with employees of the Adviser or the Administrator exists or, to the knowledge
of the Adviser, is contemplated or threatened, and the Adviser is not aware of any existing or imminent labor disturbance by, or dispute
with, the employees, except in each case as would not reasonably be expected to result in an Adviser Material Adverse Effect.
(xvi) Accounting
Controls. The Adviser maintains a system of internal accounting controls sufficient to provide reasonable assurance that (A) transactions
effectuated by the Adviser under the Investment Advisory Agreement are executed in accordance with its management’s general or
specific authorization, (B) access to the Company’s consolidated assets that are in its possession or control is permitted
only in accordance with its management’s general or specific authorization, (C) transactions for which the Adviser has bookkeeping
and record-keeping responsibility under the Investment Advisory Agreement are recorded as necessary to permit preparation of the Company’s
financial statements in conformity with GAAP and to maintain accountability for the Company’s assets, and (D) the recorded
accountability for such assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect
to any differences.
(xvii) Financial
Resources. The Adviser has the financial resources available to it necessary for the performance of its services and obligations
as contemplated by the Registration Statement, the General Disclosure Package, the Prospectus and the Investment Advisory Agreement.
(c) Officer’s
Certificates. Any certificate signed by any officer of the Company or the Adviser delivered to the Representative or to counsel for
the Underwriters shall be deemed a representation and warranty by the Company or the Adviser, as applicable, to each Underwriter as to
the matters covered thereby.
2. Agreements
to Sell and Purchase. The Company agrees to sell to the several Underwriters, and each Underwriter, upon the basis of the representations
and warranties herein contained but subject to the conditions hereinafter stated, agrees severally and not jointly to purchase from the
Company, at the price (the “Purchase Price”) set forth in Schedule II, the aggregate principal amount of Securities
set forth in Schedule I hereto opposite the name of such Underwriter, plus any additional aggregate principal amount of Securities
which such Underwriter may become obligated to purchase pursuant to the provisions of Section 2 and Section 10
hereof.
13
During the period of 90 days
from the date of the Prospectus, the Company will not, without the prior written consent of the Representative, directly or indirectly
offer, pledge, sell, contract to sell, grant any option for the sale of or otherwise transfer or dispose of any debt securities issued
or guaranteed by the Company or any securities convertible into or exercisable or exchangeable for debt securities issued or guaranteed
by the Company or file any registration statement under the Securities Act with respect to any of the foregoing; provided that the foregoing
limitation will not apply to the Company’s ability to file a post-effective amendment to the Registration Statement for purposes
of adding this Agreement, the Indenture and certain other documents related to the transactions contemplated by this Agreement as exhibits
to the Registration Statement.
3. Terms
of Public Offering. The Company is advised by the Representative that the Underwriters propose to make a public offering of their
respective portions of the Securities as soon after this Agreement has become effective as in the Representative’s judgment is
advisable. The Company is further advised by the Representative that the Securities are to be offered to the public from time to time
in one or more negotiated transactions at prices that may be different than par. These sales may occur at market prices prevailing at
the time of sale, at prices related to such prevailing market prices, or at negotiated prices.
4. Payment
and Delivery. Payment for the Notes to be sold by the Company shall be made to the Company in Federal or other funds immediately
available in New York City against delivery of such Notes for the respective accounts of the several Underwriters at the offices of Eversheds
Sutherland (US) LLP, 1114 Sixth Ave, New York, New York 10036, or at such other places as shall be agreed upon by the Representative
and the Company at 10:00 a.m. New York City time on May 27, 2026, or at such other time on the same or such other date as shall
be designated in writing by the Representative. The time and date of such payment are hereinafter referred to as the “Closing
Date.”
The Notes shall be registered
in such names as the Representative shall request in writing not later than one full business day prior to the Closing Date. The Notes
shall be delivered to the Representative on the Closing Date for the respective accounts of the several Underwriters, with any transfer
taxes payable in connection with the transfer of the Securities to the Underwriters duly paid against payment of the Purchase Price therefor.
5. Conditions
to the Underwriters’ Obligations. The several obligations of the Underwriters are subject to the following conditions:
(a) Subsequent
to the execution and delivery of this Agreement and prior to the Closing Date:
(i) there
shall not have occurred any downgrading, nor shall any notice have been given of any intended or potential downgrading or of any review
for a possible change that does not indicate the direction of the possible change, in the rating accorded any of the securities of the
Company by any “nationally recognized statistical rating organization,” as such term is defined in Section 3(a)(62)
of the Exchange Act;
(ii) there
shall not have occurred any change, or any development involving a prospective change, in the condition, financial or otherwise, or in
the earnings, business or operations of the Company from that set forth in the General Disclosure Package as of the date of this Agreement
that, in the judgment of the Representative, is material and adverse and that makes it, in the judgment of the Representative, impracticable
to market the Securities on the terms and in the manner contemplated in the General Disclosure Package;
(iii) there
shall not have occurred any change, or any development involving a prospective change, in the condition, financial or otherwise, or in
the business or operations of the Adviser from that set forth in the General Disclosure Package as of the date of this Agreement that,
in the judgment of the Representative, is material and adverse and that makes it, in the judgment of the Representative, impracticable
to market the Securities on the terms and in the manner contemplated in the General Disclosure Package; and
(iv) the
Company and the Trustee shall have executed and delivered the Indenture and the Securities.
(b) The
Underwriters shall have received on the Closing Date:
(i) a
certificate, dated the Closing Date and signed by an executive officer of the Company, in the form attached as Exhibit B
hereto; and
14
(ii) a
certificate, dated the Closing Date and signed by an executive officer of the Adviser, to the effect that the representations and warranties
of the Adviser contained in this Agreement are true and correct as of the Closing Date and that the Adviser has complied with all of
the agreements and satisfied all of the conditions on its part to be performed or satisfied hereunder on or before the Closing Date.
The officer signing
and delivering such certificates may rely upon the best of his or her knowledge as to proceedings threatened.
(c) The
Underwriters shall have received on the Closing Date:
(i) an
opinion and negative assurance letter of Dechert LLP, outside counsel for the Company, dated the Closing Date, to the effect set forth
in Exhibit A hereto; and
(ii) an
opinion and negative assurance letter of Eversheds Sutherland (US) LLP, counsel for the Underwriters, dated the Closing Date.
The opinion of
Dechert LLP described in clause (c)(i) above shall be rendered to the Underwriters at the request of the Company and shall so state
therein.
(d) The
Underwriters shall have received, on the Closing Date, reasonably satisfactory evidence of the good standing of the Company, the Adviser
and the Administrator in their respective jurisdictions of organization and their good standing as foreign entities in such other jurisdictions
as the Underwriters may reasonably request, in each case in writing or by any standard form of telecommunication from the appropriate
governmental authorities of such jurisdictions.
(e) The
Underwriters shall have received, on each of the date hereof and the Closing Date, a certificate dated as of the Closing Date of the
Chief Financial Officer of the Company in substantially the form of Exhibit C hereto.
6. Covenants
of the Company. The Company covenants with each Underwriter as follows:
(a) To
furnish to the Representative, without charge, two signed copies of the Registration Statement (including exhibits thereto) and, for
delivery to each other Underwriter, a conformed copy of the Registration Statement (without exhibits thereto) and to furnish to the Representative
in New York City, without charge, prior to 10:00 a.m. New York City time on the business day next succeeding the date of this Agreement
and during the period mentioned in Section 6(d) or 6(e) below, as applicable, as many copies of the General Disclosure
Package, the Prospectus and any supplements and amendments thereto or to the Registration Statement as the Representative may reasonably
request.
(b) Before
amending or supplementing the Registration Statement, the General Disclosure Package or the Prospectus, to furnish to the Representative
a copy of each such proposed amendment or supplement and not to file any such proposed amendment or supplement to which the Representative
reasonably objects, and to file with the Commission within the applicable period specified in Rule 424(b) under the Securities
Act any prospectus required to be filed pursuant to such rule.
(c) Additional
Disclosure Items. The Company represents and agrees that, without the prior consent of the Representative, (i) it will not distribute
any offering material other than the Registration Statement, the Prospectus, the General Disclosure Package and the Additional Disclosure
Items, and (ii) it has not made and will not make any offer relating to the Securities that would constitute a “free writing
prospectus,” as defined in Rule 405 under the Securities Act, and which the parties agree for the purposes of this Agreement
includes (x) any “advertisement,” as defined in Rule 482 under the Securities Act and (y) any sales literature,
materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering
of the Securities, including any in-person road show or investor presentations (including slides and scripts relating thereto) made to
investors by or on behalf of the Company (each of the materials and information referred to in this Section 6(c) are
herein referred to as an “Additional Disclosure Item”). Any Additional Disclosure Item the use of which has been consented
to by the Representative is listed on Schedule III hereto.
(d) If
the General Disclosure Package is being used to solicit offers to buy the Securities at a time when the Prospectus is not yet available
to prospective purchasers and any event shall occur or condition exist as a result of which it is necessary to amend or supplement the
General Disclosure Package in order to make the statements therein, in the light of the circumstances, not misleading, or if any event
shall occur or condition exist as a result of which the General Disclosure Package conflicts with the information contained in the Registration
Statement then on file, or if, in the opinion of counsel for the Underwriters, it is necessary to amend or supplement the General Disclosure
Package to comply with applicable law, forthwith to prepare, file with the Commission and furnish, at its own expense, to the Underwriters
and to any dealer upon request, either amendments or supplements to the General Disclosure Package so that the statements in the General
Disclosure Package as so amended or supplemented will not, in the light of the circumstances when the General Disclosure Package is delivered
to a prospective purchaser, be misleading, or so that the General Disclosure Package, as amended or supplemented, will no longer conflict
with the Registration Statement, or so that the General Disclosure Package, as amended or supplemented, will comply with applicable law.
15
(e) If,
during such period after the first date of the public offering of the Securities as in the opinion of counsel for the Underwriters the
Prospectus is required by law to be delivered in connection with sales by an Underwriter or dealer, any event shall occur or condition
exist as a result of which it is necessary to amend or supplement the Prospectus in order to make the statements therein, in the light
of the circumstances when the Prospectus is delivered to a purchaser, not misleading, or if, in the opinion of counsel for the Underwriters,
it is necessary to amend or supplement the Prospectus to comply with applicable law, forthwith to prepare, file with the Commission and
furnish, at its own expense, to the Underwriters and to the dealers (whose names and addresses the Representative will furnish to the
Company) to which Securities may have been sold by the Representative on behalf of the Underwriters, and to any other dealers upon request,
either amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not, in
the light of the circumstances when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus, as amended or
supplemented, will comply with applicable law.
(f) To
endeavor to qualify the Securities for offer and sale under the securities or “blue sky” laws of such jurisdictions as the
Representative shall reasonably request.
(g) To
make generally available to the Company’s security holders and to the Representative as soon as practicable an earnings statement
covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the date of this Agreement
which shall satisfy the provisions of Section 11(a) of the Securities Act and the rules and regulations of the Commission
thereunder.
(h) To
use reasonable efforts to maintain its status as a business development company under the 1940 Act; provided, however, that the Company
may only cease to be, or withdraw its election to be treated as, a business development company with the approval of its Board of Directors
and a vote of stockholders as required by Section 58 of the 1940 Act.
(i) To
use reasonable efforts to qualify and elect to be treated as a regulated investment company under subchapter M of the Code and to maintain
such qualification and election in effect for each full fiscal year during which it is a business development company under the 1940
Act.
(j) To
cooperate with the Representative and use its commercially reasonable efforts to permit the offered Securities to be eligible for clearance
and settlement through the facilities of DTC.
7. Expenses.
Whether or not the transactions contemplated in this Agreement are consummated or this Agreement is terminated, the Company agrees to
pay or cause to be paid all expenses incident to the performance of its obligations under this Agreement, including: (i) the fees,
disbursements and expenses of the Company’s counsel and the Company’s accountants in connection with the registration and
delivery of the Securities under the Securities Act and all other fees or expenses in connection with the preparation and filing of the
Registration Statement, the General Disclosure Package, the Prospectus and amendments and supplements to any of the foregoing, including
all printing costs associated therewith, and the mailing and delivering of copies thereof to the Underwriters and dealers, in the quantities
hereinabove specified, (ii) all costs and expenses related to the transfer and delivery of the issued Securities to the Underwriters,
including any transfer or other taxes payable thereon, (iii) the cost of printing or producing any “blue sky” or legal
memorandum in connection with the offer and sale of the Securities under state securities laws, and all expenses in connection with the
qualification of the Securities for offer and sale under state securities laws as provided in Section 6(f) hereof, including
filing fees and the reasonable fees and disbursements of counsel for the Underwriters in connection with such qualification and in connection
with the “blue sky” or legal memorandum, (iv) the costs and expenses of any trustee, (v) the costs and charges
of any transfer agent, registrar or depository, (vi) the costs and expenses of the Company relating to investor presentations on
any “road show” undertaken in connection with the marketing of the offering of the Securities, including, without limitation,
expenses associated with the preparation or dissemination of any electronic road show, expenses associated with the production of road
show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations with the prior
approval of the Company, travel and lodging expenses of the representatives and officers of the Company and any such consultants, and
the cost of any aircraft chartered in connection with the road show, (vii) the document production charges and expenses associated
with printing this Agreement, the Indenture, the Securities and such other documents as may be required in connection with the offering,
and (viii) all other costs and expenses incident to the performance of the obligations of the Company hereunder for which provision
is not otherwise made in this Section 7. It is understood, however, that except as provided in this Section 7,
Section 8 and the last paragraph of Section 10 below, the Underwriters will pay all of their costs and expenses,
including fees and disbursements of their counsel (except as provided for above in Section 7(iii)), transfer taxes payable
on resale of any of the Securities by them and any advertising expenses connected with any offers they may make.
16
8. Indemnity
and Contribution.
(a)
(i) The
Company agrees to indemnify and hold harmless each Underwriter, each affiliate of any Underwriter within the meaning of Rule 405
under the Securities Act, the officers, directors, employees, partners and members of any of the foregoing, and each person, if any,
who controls any Underwriter within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act,
from and against any and all losses, claims, damages and liabilities (including, without limitation, any legal or other expenses reasonably
incurred in connection with defending or investigating any such action or claim) caused by any untrue statement or alleged untrue statement
of a material fact contained in the Registration Statement or any amendment thereof, the General Disclosure Package, any Additional Disclosure
Item, or the Prospectus or any amendment or supplement thereto, or caused by any omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as such losses, claims,
damages or liabilities are caused by any such untrue statement or omission or alleged untrue statement or omission based upon information
relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representative expressly for use therein.
(ii) The
Adviser agrees, severally and not jointly, to indemnify and hold harmless each Underwriter, each affiliate of any Underwriter within
the meaning of Rule 405 under the Securities Act, the officers, directors, employees, partners and members of any of the foregoing,
and each person, if any, who controls any Underwriter within the meaning of either Section 15 of the Securities Act or Section 20
of the Exchange Act, to the same extent as the foregoing indemnity from the Company to such Underwriter, but only to the extent that
such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration Statement, the General
Disclosure Package, any Additional Disclosure Item or the Prospectus or any amendment or supplement thereto in reliance upon and in conformity
with written information furnished to the Company by the Adviser expressly for use therein.
(b) Each
Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, the Adviser, the directors of the Company,
the officers of the Company who sign the Registration Statement and each person, if any, who controls the Company within the meaning
of either Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the foregoing indemnity
from the Company to such Underwriter, but only with reference to information relating to such Underwriter furnished to the Company in
writing by such Underwriter through the Representative expressly for use in the Registration Statement, the General Disclosure Package,
any Additional Disclosure Item or the Prospectus or any amendment or supplement thereto. For purposes of this Agreement, the only information
so furnished shall be the Underwriter Information.
17
(c) In
case any proceeding (including any governmental investigation) shall be instituted involving any person in respect of which indemnity
may be sought pursuant to Section 8(a) or Section 8(b), such person (the “indemnified party”)
shall promptly notify the person against whom such indemnity may be sought (the “indemnifying party”) in writing (but
failure to so notify an indemnifying party shall not relieve such indemnifying party from any liability hereunder to the extent such
indemnifying party is not materially prejudiced as a result thereof), and the indemnifying party, upon request of the indemnified party,
shall retain counsel reasonably satisfactory to the indemnified party to represent the indemnified party and any others the indemnifying
party may designate in such proceeding and shall pay the fees and disbursements of such counsel related to such proceeding. In any such
proceeding, any indemnified party shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be
at the expense of such indemnified party unless (i) the indemnifying party and the indemnified party shall have mutually agreed
to the retention of such counsel or (ii) the named parties to any such proceeding (including any impleaded parties) include both
the indemnifying party and the indemnified party and representation of both parties by the same counsel would be inappropriate due to
actual or potential differing interests between them. It is understood that the indemnifying party shall not, in respect of the legal
expenses of any indemnified party in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the
fees and expenses of more than one separate firm (in addition to any local counsel) for all such indemnified parties, and that all such
fees and expenses shall be reimbursed as they are incurred. In the case of any such separate firm for the Underwriters and such control
persons and affiliates of any Underwriters, such firm shall be designated in writing by the Representative. In the case of any such separate
firm for the Company, and such directors, officers and control persons of the Company, such firm shall be designated in writing by the
Company. The indemnifying party shall not be liable for any settlement of any proceeding effected without its written consent, but if
settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified
party from and against any loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at
any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of
counsel as contemplated by the second and third sentences of this Section 8(c), the indemnifying party agrees that it shall
be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more
than 30 days after receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying party shall not have reimbursed
the indemnified party in accordance with such request prior to the date of such settlement. No indemnifying party shall, without the
prior written consent of the indemnified party, effect any settlement of any pending or threatened proceeding in respect of which any
indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party, unless such
settlement (x) includes an unconditional release of such indemnified party from all liability on claims that are the subject matter
of such proceeding and (y) does not include a statement as to or an admission of fault, culpability or a failure to act by or on
behalf of any indemnified party.
(d) To
the extent the indemnification provided for in Section 8(a) or Section 8(b) is unavailable to an indemnified
party or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each indemnifying party under
such section, in lieu of indemnifying such indemnified party thereunder, shall contribute to the amount paid or payable by such indemnified
party as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative
benefits received by the indemnifying party or parties on the one hand and the indemnified party or parties on the other hand from the
offering of the Securities or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such
proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above, but also the relative fault
of the indemnifying party or parties on the one hand and of the indemnified party or parties on the other hand in connection with the
statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations.
The relative benefits received by the Company on the one hand and the Underwriters on the other hand in connection with the offering
of the Securities shall be deemed to be in the same respective proportions as the net proceeds from the offering of the Securities (before
deducting expenses) received by the Company and the difference between (x) the aggregate price to the public received by the Underwriters
and (y) the aggregate price paid by the Underwriters to the Company for the Securities, bear to the aggregate public offering price
of the Securities. The relative fault of the Company on the one hand and the Underwriters on the other hand shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company or by the Underwriters and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or omission. The Underwriters’ respective obligations
to contribute pursuant to this Section 8 are several in proportion to the respective principal amount of Securities they
have purchased hereunder, and not joint.
(e) The
Company, the Adviser and the Underwriters agree that it would not be just or equitable if contribution pursuant to this Section 8
were determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other
method of allocation that does not take account of the equitable considerations referred to in Section 8(d). The amount paid
or payable by an indemnified party as a result of the losses, claims, damages and liabilities referenced in Section 8(d) shall
be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section 8,
no Underwriter shall be required to contribute any amount in excess of the amount by which the total price of the Securities underwritten
by it and distributed to the public exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason
of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within
the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of
such fraudulent misrepresentation. The remedies provided for in this Section 8 are not exclusive and shall not limit any
rights or remedies which may otherwise be available to any indemnified party at law or in equity.
18
(f) The
indemnity and contribution provisions contained in this Section 8 and the representations, warranties and other statements
of the Company contained in this Agreement shall remain operative and in full force and effect regardless of (i) any termination
of this Agreement, (ii) any investigation made by or on behalf of any Underwriter, any person controlling any Underwriter or any
affiliate of any Underwriter, or the Company, its officers or directors or any person controlling the Company, and (iii) acceptance
of and payment for any of the Securities.
(g) Notwithstanding
any other provision of this Section 8, no party shall be entitled to indemnification or contribution under this Agreement
in violation of Section 17(i) of the 1940 Act.
9. Termination.
The Underwriters may terminate this Agreement by notice given by the Representative to the Company, if after the execution and delivery
of this Agreement and prior to the Closing Date (i) trading generally shall have been suspended or materially limited on, or by,
as the case may be, any of the NYSE, the NYSE American or the NASDAQ Global Select Market or other relevant exchanges, (ii) there
shall have been a downgrade in the rating of any debt of the Company or any subsidiary by any “nationally recognized statistical
rating organization,” as such term is defined for purposes of Section 3(a)(62) of the Exchange Act, (iii) trading of
any securities of the Company shall have been suspended on any exchange or in any over-the-counter market, (iv) a material disruption
in securities settlement, payment or clearance services in the United States or other relevant jurisdiction shall have occurred, (v) any
moratorium on commercial banking activities shall have been declared by Federal or New York State authorities, or (vi) there shall
have occurred any outbreak or escalation of hostilities, or any change in financial markets or any calamity or crisis that, in the judgment
of the Representative, is material and adverse and which, singly or together with any other event specified in this clause (vi), makes
it, in the judgment of the Representative, impracticable or inadvisable to proceed with the offer, sale or delivery of the Securities
on the terms and in the manner contemplated in the General Disclosure Package or the Prospectus.
10. Effectiveness.
This Agreement shall become effective upon the execution and delivery hereof by the parties hereto.
If this Agreement shall be
terminated by the Underwriters, or any of them, because of any failure or refusal on the part of the Company to comply with the terms
or to fulfill any of the conditions of this Agreement, or if for any reason the Company shall be unable to perform its obligations under
this Agreement, the Company will reimburse the Underwriters or such Underwriter as has so terminated this Agreement with respect to itself,
severally in proportion to the respective principal amount of Securities sold by the Company for all out-of-pocket expenses (including
the fees and disbursements of their counsel) reasonably incurred by such Underwriters in connection with this Agreement or the offering
contemplated hereunder.
11. Entire
Agreement.
(a) This
Agreement, together with any contemporaneous written agreements and any prior written agreements (to the extent not superseded by this
Agreement) that relate to the offering of the Securities, represents the entire agreement between the Company and the Adviser, on the
one hand, and the Underwriters, on the other, with respect to the preparation of the General Disclosure Package, the Prospectus, the
conduct of the offering, and the purchase and sale of the Securities.
(b) The
Company acknowledges that in connection with the offering of the Securities:
(i) the
Underwriters have acted at arm’s length, are not agents of, and owe no fiduciary duties to, the Company or any other person;
(ii) the
Underwriters owe the Company only those duties and obligations set forth in this Agreement and prior written agreements (to the extent
not superseded by this Agreement), if any;
(iii) the
Underwriters may have interests that differ from those of the Company;
19
(iv) the
Underwriters have not provided any legal, accounting, regulatory or tax advice with respect to the offering contemplated hereby and the
Company has consulted its own legal, accounting, regulatory and tax advisors to the extent it deemed appropriate; and
(v) none
of the activities of the Underwriters in connection with the transactions contemplated herein constitutes a recommendation, investment
advice, or solicitation of any action by the Underwriters with respect to any entity or natural person.
The Company waives to the full extent
permitted by applicable law any claims it may have against the Underwriters arising from an alleged breach of fiduciary duty in connection
with the offering of the Securities.
12. Counterparts.
This Agreement may be signed in two or more counterparts, each of which shall be an original, with the same effect as if the signatures
thereto and hereto were upon the same instrument.
13. Tax
Disclosure. Notwithstanding any other provision of this Agreement, from the commencement of discussions with respect to the transactions
contemplated hereby, the Company (and each employee, representative or other agent of the Company) may disclose to any and all persons,
without limitation of any kind, the tax treatment and tax structure (as such terms are used in Sections 6011, 6111 and 6112 of the Code
and the Treasury Regulations promulgated thereunder) of the transactions contemplated by this Agreement and all materials of any kind
(including opinions or other tax analyses) that are provided relating to such tax treatment and tax structure.
14. Recognition
of the U.S. Special Resolution Regimes.
(a) In
the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer
from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent
as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation,
were governed by the laws of the United States or a state of the United States.
(b) In
the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under
a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to
be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement
were governed by the laws of the United States or a state of the United States.
(c) For
purposes of this Section 14, a “BHC Act Affiliate” has the meaning assigned to the term “affiliate”
in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k). “Covered Entity” means any of the following:
(i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b); (ii) a
“covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or (iii) a
“covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b). “Default
Right” has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81,
47.2 or 382.1, as applicable. “U.S. Special Resolution Regime” means each of (i) the Federal Deposit Insurance
Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act
and the regulations promulgated thereunder.
15. Applicable
Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York.
16. Headings.
The headings of the sections of this Agreement have been inserted for convenience of reference only and shall not be deemed a part of
this Agreement.
17. Notices.
All communications hereunder shall be in writing and effective only upon receipt and, if to the Underwriters, shall be delivered,
mailed or sent to the Representative in care of Oppenheimer & Co. Inc., 85 Broad Street, 23rd Floor, New York, NY
10004, with a copy, which shall not constitute notice, to Eversheds Sutherland (US) LLP, 700 6th Street NW, Washington, DC 20001, attention
of Payam Siadatpour, Esq., and, if to the Company, shall be delivered, mailed or sent to Runway Growth Finance Corp., 205 N. Michigan
Ave., Suite 4200, Chicago, IL 60601, with a copy, which shall not constitute notice, to Dechert LLP, 1900 K Street NW, Washington,
DC 20006, attention of Harry S. Pangas, Esq.
[SIGNATURE PAGE FOLLOWS]
20
Very truly yours,
RUNWAY GROWTH FINANCE CORP.
By:
/s/Thomas
B. Raterman
Name:
Thomas B. Raterman
Title: Chief
Financial Officer
Runway
Growth Capital LLC
By:
/s/Thomas
B. Raterman
Name:
Thomas B. Raterman
Title: Chief
Financial Officer
[Company Signature Page - Underwriting
Agreement (Institutional Notes – May 2026)]
CONFIRMED AND ACCEPTED,
as of the date first above written:
By:
OPPENHEIMER &
CO. INC.
By:
/s/
JD Nelson
Name:
JD Nelson
Title:
Managing Director
For itself and as Representative of the other Underwriter named in
Schedule I hereto.
[Underwriter Signature Page - Underwriting
Agreement (Institutional Notes – May 2026)]
Schedule I
Underwriter
Principal
Amount of Notes to
be Purchased
Oppenheimer &
Co. Inc.
$
45,000,000.00
BC Partners Securities, LLC
5,000,000.00
Total:
$
50,000,000.00
Schedule II
1. Term sheet containing the terms of the Notes, substantially in the form
of Annex A hereto.
Annex
A
Runway Growth Finance Corp.
$50,000,000
7.00% Notes Due 2029
Pricing Term Sheet
May 27, 2026
The following sets forth the final terms of the 7.00% Notes due
2029 (the “Notes”) and should only be read together with the prospectus dated March 19, 2025, relating
to these securities. All references to dollar amounts are references to U.S. dollars.
Issuer:
Runway
Growth Finance Corp. (the “Company”)
Title of the Securities:
7.00%
Notes due 2029
Aggregate Principal Amount Being Offered:
$50,000,000
Issue Price:
98.859%
Principal Payable at Maturity:
100%
of the aggregate principal amount.
Type of Note:
Fixed-rate
note
No Established Trading Market:
The
Company does not intend to list the Notes on any securities exchange or automated dealer quotation system. We cannot assure you that
a liquid market for the Notes will develop or be maintained.
Stated Maturity Date:
December
1, 2029
Interest Rate:
7.00%
per year, payable semi-annually in arrears
Underwriting Discount:
1.50%
Net Proceeds to the Issuer, before Expenses:
97.359%
Day Count Basis:
360-day
year of twelve 30-day months
Trade Date:
May
27, 2026
Settlement Date:**
May
29, 2026 (T+2)
Date Interest Starts Accruing:
May
29, 2026
Interest
Payment Dates:
June
1 and December 1 of each year, commencing on December 1, 2026. If an interest payment date falls on a non-business day, the applicable
interest payment will be made on the next business day and no additional interest will accrue as a result of such delayed payment.
Interest
Periods:
The
initial interest period will be the period from and including May 29, 2026, to, but excluding, the initial interest payment date,
and the subsequent interest periods will be the periods from and including an interest payment date to, but excluding, the next interest
payment date or the stated maturity date, as the case may be.
Specified
Currency:
U.S.
Dollars
Denominations:
The
Company will issue the Notes in denominations of $2,000 and integral multiples of $1,000 in excess thereof.
Business
Day:
Each
Monday, Tuesday, Wednesday, Thursday and Friday that is not a day on which banking institutions in New York City or the place of
payment are authorized or required by law or executive order to close.
Optional
Redemption:
Prior
to June 1, 2029 (six months prior to the maturity date of the Notes) (the “Par Call Date”), the Company may redeem the
Notes at its option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage of
principal amount and rounded to three decimal places) equal to the greater of: (1)(a)the sum of the present values of the remaining
scheduled payments of principal and interest thereon discounted to the redemption date (assuming the Notes matured on the Par Call
Date) on a semi-annual basis at the Treasury Rate plus 50 basis points less (b)interest accrued to the date of redemption, and (2)100%
of the principal amount of the Notes to be redeemed, plus, in either case, accrued and unpaid interest thereon, but not including
the redemption date.
On
or after the Par Call Date, the Company may redeem the Notes, in whole or in part, at any time and from time to time, at a redemption
price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest, if any, to but excluding,
the redemption date.
Offer
to Purchase upon a Change of Control Repurchase Event:
If
a Change of Control Repurchase Event occurs prior to maturity, unless the Company has exercised its right to redeem the Notes
in full, holders will have the right, at their option, to require the Company to repurchase for cash some or all of the Notes at
a repurchase price equal to 100% of the principal amount of the Notes being repurchased, plus accrued and unpaid interest to, but
not including, the repurchase date.
Use
of Proceeds
The
Company intends to use the net proceeds from this offering to repay indebtedness, including the repayment of its Credit Facility
and for the Company’s general corporate purposes.
CUSIP/ISIN
78163D
AB6 / US78163DAB64
Sole
Book-Running Manager:
Oppenheimer&
Co. Inc.
Co-Manager:
BC
Partners Securities, LLC
Trustee,
Paying Agent and Security Registrar:
U.S.
Bank Trust Company, National Association
* A securities rating is
not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal
at any time.
** Under Rule 15c6-1
of the Securities Exchange Act of 1934, as amended, trades in the secondary market generally
are required to settle in one business day, unless the parties to any such trade expressly
agree otherwise. Accordingly, purchasers who wish to trade the Notes on any date prior to
the business day before delivery thereof will be required, by virtue of the fact that the
Notes initially will settle T+2, to specify an alternate settlement cycle at the time of
any such trade to prevent a failed settlement. Purchasers of the Notes who wish to trade
should consult their own advisor prior to the closing.
Investors are advised to carefully consider
the investment objectives, risks, charges and expenses of the Company before investing.
This pricing term sheet is not an offer to
sell or the solicitation of offers to buy, nor will there be any sale of the Notes referred to in this pricing term sheet, in any jurisdiction
where such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such
jurisdiction.
A shelf registration statement (including
a prospectus) relating to these securities is on file with, and has been declared effective by, the SEC. Before you invest, you should
read the prospectus in that registration statement and other documents the Company has filed with the SEC for more complete information
about the Company and this offering. You may obtain these documents for free by visiting EDGAR on the SEC’s website at www.sec.gov.
Alternatively, the Company, the underwriter or any dealer participating in the offering will arrange to send you the prospectus if you
request it from Oppenheimer & Co. Inc., 85 Broad Street, 23rd Floor, New York, NY 10004 or by calling (800) 966 1559.
Schedule III
1. Term
Sheet dated May 27, 2026, substantially in the form attached hereto as Annex A of Schedule II, containing the terms
of the Securities, filed with the Commission on May 27, 2026 pursuant to Rule 433 under the Securities Act.
Exhibit A
Form of
Opinion of Dechert llp
[Under Separate Cover]
29
Exhibit B
Form of
Officers’ Certificate
[Under Separate Cover]
30
Exhibit C
Form of
chief financial officer certificate
[Under Separate Cover]
31
EX-4.2 — EXHIBIT 4.2
EX-4.2
Filename: tm2616014d1_ex4-2.htm · Sequence: 3
Exhibit 4.2
Execution Version
FOURTH SUPPLEMENTAL INDENTURE
between
RUNWAY GROWTH FINANCE CORP.
and
U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,
as Trustee
Dated as of May 29, 2026
FOURTH SUPPLEMENTAL INDENTURE
THIS FOURTH SUPPLEMENTAL INDENTURE
(this “Fourth Supplemental Indenture”), dated as of May 29, 2026, is between Runway Growth Finance Corp., a Maryland
corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).
All capitalized terms used herein shall have the meaning set forth in the Base Indenture (as defined below).
RECITALS OF THE COMPANY
The Company and the Trustee
executed and delivered an Indenture, dated as of July 28, 2022 (the “Base Indenture” and, as supplemented by this
Fourth Supplemental Indenture, the “Indenture”), to provide for the issuance by the Company from time to time of the
Company’s unsecured debentures, notes or other evidences of indebtedness (the “Securities”), to be issued in
one or more series as provided in the Base Indenture.
The Company desires to initially
issue and sell up to $50,000,000 aggregate principal amount of the Company’s 7.00% Notes due 2029 (the “2029 Notes”).
Sections 901(4) and 901(6) of
the Base Indenture provide that, without the consent of Holders of the Securities of any series issued under the Indenture, the Company,
when authorized by or pursuant to a Board Resolution, and the Trustee, at any time and from time to time, may enter into one or more indentures
supplemental to the Base Indenture to (i) change or eliminate any of the provisions of the Indenture when there is no Security Outstanding
of any series created prior to the execution of a supplemental indenture that is entitled to the benefit of such provision and (ii) establish
the form or terms of Securities of any series as permitted by Section 201 and Section 301 of the Base Indenture.
The Company desires to establish
the form and terms of the 2029 Notes and to modify, alter, supplement and change certain provisions of the Base Indenture for the benefit
of the Holders of the 2029 Notes (except as may be provided in a future supplemental indenture to the Indenture (“Future Supplemental
Indenture”)).
The Company has duly authorized
the execution and delivery of this Fourth Supplemental Indenture to provide for the issuance of the 2029 Notes and all acts and things
necessary to make this Fourth Supplemental Indenture a valid, binding, and legal obligation of the Company and to constitute a valid agreement
of the Company, in accordance with its terms, have been done and performed.
NOW, THEREFORE, THIS INDENTURE WITNESSETH:
For and in consideration of
the premises and the purchase of the 2029 Notes by the Holders thereof, it is mutually agreed, for the equal and proportionate benefit
of all Holders of the 2029 Notes, as follows:
ARTICLE I
TERMS OF THE 2029 NOTES
Section 101. Terms
of the 2029 Notes. The following terms relating to the 2029 Notes are hereby established:
(a) The 2029 Notes shall
constitute a series of Securities having the title “7.00% Notes due 2029” and shall be designated as “Senior Securities”
under the Indenture. The 2029 Notes shall bear a CUSIP number of 78163D AB6 and an ISIN number of US78163DAB64.
(b) The aggregate principal
amount of the 2029 Notes that may be initially authenticated and delivered under the Indenture (except for 2029 Notes authenticated and
delivered upon registration of, transfer of, or in exchange for, or in lieu of, other 2029 Notes pursuant to Sections 304, 305, 306,
906 or 1107 of the Base Indenture) shall be $50,000,000 aggregate principal amount. Under a Board Resolution, Officers’ Certificate
pursuant to Board Resolutions or a Future Supplemental Indenture, the Company may from time to time, without the consent of the Holders
of 2029 Notes, issue additional 2029 Notes (in any such case, “Additional Notes”) having the same ranking and the same
interest rate, maturity and other terms as the 2029 Notes initially issued. Any Additional Notes and the existing 2029 Notes shall constitute
a single series under the Indenture, and all references to the relevant 2029 Notes herein shall include the Additional Notes unless the
context otherwise requires.
(c) The entire outstanding
principal of the 2029 Notes shall be payable on December 1, 2029 unless earlier redeemed or repurchased in accordance with the provisions
of the Indenture.
(d) The rate at which
the 2029 Notes shall bear interest shall be 7.00% per annum. The date from which interest shall accrue on the 2029 Notes shall be May 29,
2026, or the most recent Interest Payment Date to which interest has been paid or provided for; the Interest Payment Dates for the 2029
Notes shall be June 1 and December 1 of each year, commencing December 1, 2026 (provided that, if an Interest Payment
Date falls on a day that is not a Business Day, then the applicable interest payment shall be made on the next succeeding Business Day,
and no additional interest shall accrue as a result of such delayed payment); the initial interest period shall be the period from and
including May 29, 2026 (or the most recent Interest Payment Date to which interest has been paid or provided for), to, but excluding,
the initial Interest Payment Date, and the subsequent interest periods shall be the periods from and including an Interest Payment Date
to, but excluding, the next Interest Payment Date or the Stated Maturity, as the case may be; the interest so payable, and punctually
paid or duly provided for, on any Interest Payment Date, shall be paid to the Person in whose name the 2029 Note (or one or more predecessor
2029 Notes) is registered at the close of business on the Regular Record Date for such interest, which shall be May 15 and November 15
(whether or not a Business Day), as the case may be, next preceding such Interest Payment Date. Payment of principal of (and premium,
if any) and any such interest on the 2029 Notes shall be made at Corporate Trust Office of the Trustee located at 111 Filmore Avenue,
St. Paul, MN 55107, Attention: Runway Growth Finance Corp. (7.00% Notes Due 2029) and at such other address as designated by the Trustee
from time to time, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public
and private debts; provided, however, that, at the option of the Company, payment of interest may be made by check mailed to the
address of the Person entitled thereto as such address shall appear in the Security Register; provided further, however, that so
long as the 2029 Notes are registered to Cede & Co., such payment will be made by wire transfer in accordance with the procedures
established by The Depository Trust Company and the Trustee. Interest on the 2029 Notes shall be computed on the basis of a 360-day year
of twelve 30-day months.
(e) The 2029 Notes shall
be initially issuable in global form (each such 2029 Note, a “Global Note”). The Global Notes and the Trustee’s
certificate of authentication thereon shall be substantially in the form of Exhibit A to this Fourth Supplemental Indenture.
Each Global Note shall represent the outstanding 2029 Notes as shall be specified therein and each shall provide that it shall represent
the aggregate amount of outstanding 2029 Notes from time to time endorsed thereon and that the aggregate amount of outstanding 2029 Notes
represented thereby may from time to time be reduced or increased, as appropriate, to reflect exchanges and redemptions. Any endorsement
of a Global Note to reflect the amount of any increase or decrease in the amount of outstanding 2029 Notes represented thereby shall be
made by the Trustee or the Security Registrar, in accordance with Sections 203 and 305 of the Base Indenture.
2
(f) The depositary for
such Global Notes (the “Depositary”) shall be The Depository Trust Company, New York, New York. The Security Registrar
with respect to the Global Notes shall be the Trustee.
(g) The 2029 Notes shall
be defeasible pursuant to Section 1402 or Section 1403 of the Base Indenture. Covenant defeasance contained in Section 1403
of the Base Indenture shall apply to the covenants contained in Sections 1007 and 1008 of the Indenture.
(h) The 2029 Notes shall
be redeemable pursuant to Section 1101 of the Base Indenture and as follows:
(i) Prior to
June 1, 2029 (six months prior to the maturity date of the 2029 Notes) (the “Par Call Date”), the Company may
redeem the 2029 Notes at the Company’s option, in whole or in part, at any time or from time to time, at a Redemption Price (expressed
as a percentage of principal amount and rounded to three decimal points) equal to the greater of: (A)(1) the sum of the present values
of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming the 2029 Notes matured
on the Par Call Date) on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 50
basis points less (2) interest accrued to the date of Redemption Date, and (B) 100% of the principal amount of the 2029 Notes
to be redeemed, plus, in either case, accrued and unpaid interest, if any, to but excluding, the Redemption Date.
Notwithstanding
the foregoing, on or after the Par Call Date, the Company may redeem the 2029 Notes, in whole or in part, at any time and from time to
time, at a Redemption Price equal to 100% of the principal amount of the 2029 Notes to be redeemed plus accrued and unpaid interest thereon
to the Redemption Date.
“Treasury
Rate” means, with respect to any Redemption Date of the 2029 Notes, the yield determined by the Company in accordance with the following
two paragraphs.
The Treasury Rate
shall be determined by the Company after 4:15 p.m., New York City time (on or after such time as yields on U.S. government securities
are posted daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the Redemption Date based
upon the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published
by the Board of Governors of the Federal Reserve System designated as “Selected Interest Rates (Daily)-H.15” (or any successor
designation or publication) (“H.15”) under the caption “U.S. government securities-Treasury constant maturities-Nominal”
(or any successor caption or heading) (“H.15 TCM”). In determining the Treasury Rate, the Company shall select, as
applicable: (1) the yield for the Treasury constant maturity on H.15 exactly equal to the period from the Redemption Date to the
Par Call Date (the “Remaining Life”); or (2) if there is no such Treasury constant maturity on H.15 exactly equal
to the Remaining Life, the two yields - one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and
one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life - and shall interpolate to
the Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal
places; or (3) if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for
the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant
maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable,
of such Treasury constant maturity from the Redemption Date.
If on the third
Business Day preceding the Redemption Date H.15 TCM is no longer published, the Company shall calculate the Treasury Rate based on the
rate per annum equal to the semiannual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding
such Redemption Date of the United States Treasury security maturing on, or with a maturity that is closest to, the Par Call Date, as
applicable. If there is no United States Treasury security maturing on the Par Call Date but there are two or more United States Treasury
securities with a maturity date equally distant from the Par Call Date, one with a maturity date preceding the Par Call Date and one with
a maturity date following the Par Call Date, the Company shall select the United States Treasury security with a maturity date preceding
the Par Call Date. If there are two or more United States Treasury securities maturing on the Par Call Date or two or more United States
Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more United States
Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices
for such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury Rate in accordance with the
terms of this paragraph, the semiannual yield to maturity of the applicable United States Treasury security shall be based upon the average
of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury
security, and rounded to three decimal places.
3
The Company’s
actions and determinations in determining the Redemption Price shall be conclusive and binding for all purposes, absent manifest error.
For the avoidance of doubt, the Trustee shall have no duty to calculate the Redemption Price, nor shall it have any duty to review or
verify the Company’s calculations of the Redemption Price.
(ii) Notice
of redemption shall be given in writing and mailed, first-class postage prepaid, by overnight courier guaranteeing next-day delivery or
sent electronically in accordance with the applicable procedures of DTC with respect to the 2029 Notes in global form, to each Holder
of the 2029 Notes to be redeemed, not less than thirty (30) nor more than sixty (60) days prior to the Redemption Date, at the
Holder’s address, facsimile number or email address appearing in the Security Register. All notices of redemption shall contain
the information set forth in Section 1104 of the Base Indenture.
(iii) Any exercise
of the Company’s option to redeem the 2029 Notes shall be done in compliance with the Investment Company Act.
(iv) If the
Company elects to redeem only a portion of the 2029 Notes, the Trustee shall determine the method for selecting the particular 2029 Notes
to be redeemed, in accordance with Section 1103 of the Base Indenture and the Investment Company Act.
(v) Unless
the Company defaults in payment of the Redemption Price, on and after the Redemption Date, interest shall cease to accrue on the 2029
Notes called for redemption hereunder.
(i) The 2029 Notes shall
not be subject to any sinking fund pursuant to Section 1201 of the Base Indenture.
(j) The 2029 Notes shall
be issuable in denominations of $2,000 and integral multiples of $1,000 in excess thereof.
(k) Holders of the 2029
Notes shall not have the option to have the 2029 Notes repaid prior to the Stated Maturity.
ARTICLE II
DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION
Section 201. Except
as may be provided in a Future Supplemental Indenture, for the benefit of the Holders of the 2029 Notes but no other series of Securities
under the Base Indenture, whether now or hereafter issued and Outstanding, Article One of the Base Indenture shall be amended by
adding or amending and restating, as applicable, the following defined terms to Section 101 thereof in appropriate alphabetical sequence,
as follows:
“‘Business
Day’, when used with respect to any Place of Payment or any other particular location referred to in this Indenture or in the
Securities, means, each Monday, Tuesday, Wednesday, Thursday and Friday that is not a day on which banking institutions in New York City
and Chicago are authorized or obligated by law or executive order to close.”
“‘Change
of Control’ means the occurrence of any of the following:
(1) the
direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation) in one or a series
of related transactions, of all or substantially all of the assets of the Company and its Controlled Subsidiaries taken as a whole to
any “person” or “group” (as those terms are used in Section 13(d)(3)) of the Exchange Act), other than to
any Permitted Holders; provided that, for the avoidance of doubt, a pledge of assets pursuant to any secured debt instrument of
the Company or its Controlled Subsidiaries shall not be deemed to be any such sale, lease, transfer, conveyance or disposition;
4
(2) the
consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any “person”
or “group” (as those terms are used in Section 13(d)(3) of the Exchange Act) (other than any Permitted Holders)
becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 promulgated under the Exchange Act), directly or
indirectly, of more than 50% of the outstanding Voting Stock of the Company, measured by voting power rather than number of shares; or
(3) the
approval by the Company’s stockholders of any plan or proposal relating to the liquidation or dissolution of the Company.”
“‘Change
of Control Repurchase Event’ means the occurrence of a Change of Control.”
“‘Controlled
Subsidiary’ means any Subsidiary of the Company, 50% or more of the outstanding equity interests of which are owned by the Company
and its direct or indirect Subsidiaries and of which the Company possesses, directly or indirectly, the power to direct or cause the direction
of the management or policies, whether through the ownership of voting equity interests, by agreement or otherwise.”
“‘Corporate
Trust Office’ means the principal designated office of the Trustee at which at any time its corporate trust business shall be
administered, which office at the date hereof is (i) solely for purposes of surrender for registration of transfer or exchange or
for presentation for payment or repurchase or for conversion is located at 111 Filmore Avenue, St. Paul, MN 55107, Attention: Runway Growth
Finance Corp., and (ii) for all other purposes is located as One Federal Street, 10th Floor, Boston, MA 02110, Attention: Runway
Growth Finance Corp., or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or
the principal designated corporate trust office of any successor Trustee (or such other address as such successor Trustee may designate
from time to time by notice to the Holders and the Company).”
“‘Exchange
Act’ means the Securities Exchange Act of 1934, as amended, and any statute successor thereto.”
“‘FATCA’
means Sections 1471 through 1474 of the Code (or any amended or successor version) and any current or future regulations or official interpretations
thereof.”
“‘FATCA Withholding
Tax’ means any withholding or deduction pursuant to an agreement described in Section 1471(b) of the Code or otherwise
imposed pursuant to FATCA.”
“‘GAAP’
means generally accepted accounting principles in the United States set forth in the opinions and pronouncements of the Accounting Principles
Board of the American Institute of Certified Public Accountants, the opinions and pronouncements of the Public Company Accounting Oversight
Board and the statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity
as have been approved by a significant segment of the accounting profession in the United States, which are in effect from time to time.”
“‘Investment
Company Act’ means the Investment Company Act of 1940, as amended, and the rules, regulations and interpretations promulgated
thereunder, to the extent applicable, and any statute successor thereto.”
“‘Noteholder
FATCA Information’ means, with respect to any Holder of a 2029 Note or Holder of an interest in a 2029 Note, information sufficient
to eliminate the imposition of, or determine the amount of, U.S. withholding tax under FATCA.”
“‘Noteholder
Tax Identification Information’ means properly completed and signed tax certifications (generally, in the case of U.S. federal
income tax, IRS Form W-9 (or applicable successor form) in the case of a person that is a “United States Person”
within the meaning of Section 7701(a)(30) of the Code or the appropriate IRS Form W-8 (or applicable successor form) in the
case of a person that is not a "United States Person" within the meaning of Section 7701(a)(30) of the Code).”
5
“‘Permitted
Holders’ means (i) the Company, (ii) one or more of the Company’s Controlled Subsidiaries and (iii) Runway
Growth Capital LLC, any control affiliate of Runway Growth Capital LLC or any entity that is advised by Runway Growth Capital LLC that
is organized under the laws of a jurisdiction located in the United States of America and in the business of managing or advising clients.”
“‘Voting Stock’
as applied to stock of any person, means shares, interests, participations or other equivalents in the equity interest (however designated)
in such person having ordinary voting power for the election of a majority of the directors (or the equivalent) of such person, other
than shares, interests, participations or other equivalents having such power only by reason of the occurrence of a contingency.”
ARTICLE III
THE SECURITIES
Section 301. Except
as may be provided in a Future Supplemental Indenture, for the benefit of the Holders of the 2029 Notes but no other series of Securities
under the Base Indenture, whether now or hereafter issued and Outstanding, Article Three of the Base Indenture shall be amended with
respect to the 2029 Notes by adding the following Section 315:
“Section 315. FATCA
Withholding. Each Holder of a 2029 Note or Holder of an interest in a 2029 Note shall provide to the Trustee, any Paying Agent or
the Company, upon its request, the Noteholder Tax Identification Information and, to the extent FATCA Withholding Tax is applicable, the
Noteholder FATCA Information. The Trustee has the right to withhold any amounts of interest (properly withholdable under law and without
any corresponding gross-up) payable to a Holder of a 2029 Note or a Holder of an interest in a 2029 Note that fails to comply with the
requirements of the preceding sentence.”
ARTICLE IV
SATISFACTION AND DISCHARGE
Section 401. Except
as may be provided in a Future Supplemental Indenture, for the benefit of the Holders of the 2029 Notes but no other series of Securities
under the Base Indenture, whether now or hereafter issued and Outstanding, Section 401 of the Base Indenture shall be amended by
replacing clause (2) thereof with the following:
“(2) the
Company has irrevocably paid or caused to be irrevocably paid all other sums payable hereunder by the Company, including sums payable
to the Trustee; and”.
ARTICLE V
COVENANTS
Section 501. Except
as may be provided in a Future Supplemental Indenture, for the benefit of the Holders of the 2029 Notes but no other series of Securities
under the Base Indenture, whether now or hereafter issued and Outstanding, Article Ten of the Base Indenture shall be amended by
adding the following new Sections 1007, 1008, and 1009, each as set forth below:
“Section 1007. Section 18(a)(1)(A) of
the Investment Company Act.
The Company hereby
agrees that for the period of time during which 2029 Notes are Outstanding, the Company will not violate, whether or not it is subject
to, Section 18(a)(1)(A) as modified by Section 61(a)(2) of the Investment Company Act or any successor provisions
thereto of the Investment Company Act, whether or not the Company continues to be subject to such provisions of the Investment Company
Act, but giving effect to any exemptive relief granted to the Company by the Commission.”
6
“Section 1008. Commission
Reports and Reports to Holders.
If, at any time,
the Company is not subject to the reporting requirements of Sections 13 or 15(d) of the Exchange Act to file any periodic reports
with the Commission, the Company agrees to furnish to the Holders of 2029 Notes and the Trustee for the period of time during which the
2029 Notes are Outstanding: (i) within 90 days after the end of the each fiscal year of the Company, audited annual financial
statements of the Company and (ii) within 45 days after the end of each fiscal quarter of the Company (other than the Company’s
fourth fiscal quarter), unaudited interim financial statements of the Company. All such financial statements shall be prepared, in all
material respects, in accordance with GAAP.”
“Section 1009. Section 18(a)(1)(B) of
the Investment Company Act.
The Company hereby
agrees that for the period of time during which the 2029 Notes are Outstanding, the Company will not violate Section 18(a)(1)(B) as
modified by Section 61(a)(2) and the definitional provisions of the Investment Company Act or any successor provisions thereto
of the Investment Company Act, whether or not the Company is subject to such provisions of the Investment Company Act, and after giving
effect to any exemptive relief granted to the Company by the Commission; provided that the Company may declare a cash dividend or distribution,
notwithstanding the prohibition contained in Section 18(a)(1)(B) as modified by Section 61(a)(2) and the definitional
provisions of the Investment Company Act, but only up to such amount as is necessary in order for the Company to maintain its status as
a regulated investment company under Subchapter M of the Code; provided, however, that the prohibition in this Section 1009 shall
not apply until such time as the Company’s asset coverage has been below the minimum asset coverage required pursuant to Section 18(a)(1)(B) as
modified by Section 61(a)(2) and the definitional provisions of the Investment Company Act or any successor provisions thereto
of the Investment Company Act (after giving effect to any exemptive relief granted to the Company by the Commission) for more than six
(6) consecutive months.”
ARTICLE VI
DEFEASANCE
Section 601. Except
as may be provided in a Future Supplemental Indenture, for the benefit of the Holders of the 2029 Notes but no other series of Securities
under the Base Indenture, whether now or hereafter issued and Outstanding, Section 1404 of the Base Indenture shall be amended by
adding the following clause (h):
“(h) In
the case of an election under Section 1402, in addition to the amounts deposited for the benefit of the Holders pursuant to
clause (a) of this Section 1404, the Company shall have irrevocably deposited or caused
to be irrevocably deposited with the Trustee all amounts then due to the Trustee under the Indenture.”
ARTICLE VII
OFFER TO REPURCHASE UPON A CHANGE OF CONTROL REPURCHASE EVENT
Section 701. Except
as may be provided in a Future Supplemental Indenture, for the benefit of the Holders of the 2029 Notes but no other series of Securities
under the Base Indenture (as supplemented or amended from time to time by one or more indentures supplemental thereto), whether now or
hereafter issued and Outstanding, Article Thirteen of the Base Indenture shall be amended by replacing Sections 1301 to 1305 with
the following:
“Section 1301.
Change of Control.
If a Change of Control
Repurchase Event occurs, unless the Company shall have exercised its right to redeem the 2029 Notes in full, the Company shall make an
offer to each Holder of the 2029 Notes to repurchase all or any part (in minimum denominations of $2,000 and integral multiples of $1,000
principal amount in excess thereof) of that Holder’s 2029 Notes at a repurchase price in cash equal to 100% of the aggregate principal
amount of 2029 Notes repurchased plus any accrued and unpaid interest on the 2029 Notes repurchased to, but not including, the date of
repurchase. Within 30 days following any Change of Control Repurchase Event or, at the Company’s option, prior to any Change of
Control, but after the public announcement of the Change of Control, the Company shall deliver a notice to each Holder (with a copy to
the Trustee) describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event and offering
to repurchase 2029 Notes on the payment date specified in the notice, which date shall be no earlier than 30 days and no later than 60
days from the date such notice is delivered. The notice shall, if delivered prior to the date of consummation of the Change of Control,
state that the offer to purchase is conditioned on the Change of Control Repurchase Event occurring on or prior to the payment date specified
in the notice. The Company shall comply with the requirements of Rule 14e-1 promulgated under the Exchange Act and any other securities
laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the 2029
Notes as a result of a Change of Control Repurchase Event.
7
To the extent that
the provisions of any securities laws or regulations conflict with this Section 1301, the Company shall comply with the applicable
securities laws and regulation and shall not be deemed to have breached its obligations under this Section 1301 by virtue of such
conflict.
On the Change of
Control Repurchase Event payment date, subject to extension if necessary to comply with the provisions of the Investment Company Act,
the Company shall, to the extent lawful:
(1) accept for
payment all 2029 Notes or portions of 2029 Notes properly tendered pursuant to its offer;
(2) deposit
with the Paying Agent an amount equal to the aggregate purchase price in respect of all 2029 Notes or portions of 2029 Notes properly
tendered; and
(3) deliver
or cause to be delivered to the Trustee the 2029 Notes properly accepted, together with an Officers’ Certificate, stating the aggregate
principal amount of 2029 Notes being purchased by the Company.
Upon receipt from
the Company, the Paying Agent will promptly remit to each Holder of Notes properly tendered the purchase price for the 2029 Notes, and
upon receipt of written direction from the Company, the Trustee shall promptly authenticate and deliver (or cause to be transferred by
book-entry) to each Holder a new 2029 Note equal in principal amount to any unpurchased portion of any Notes surrendered; provided that
each new 2029 Note shall be in a minimum principal amount of $2,000 or an integral multiple of $1,000 in excess thereof.
If any Repayment
Date upon a Change of Control Repurchase Event falls on a day that is not a Business Day, then the required payment shall be made on the
next succeeding Business Day, and no additional interest shall accrue as a result of such delayed repayment.
The Company shall
not be required to make an offer to repurchase the 2029 Notes upon a Change of Control Repurchase Event if a third party makes an offer
in respect of the 2029 Notes in a manner, at the time and otherwise in compliance with the requirements for an offer made by the Company,
and such third party purchases all 2029 Notes properly tendered and not withdrawn under its offer.”
ARTICLE VIII
MISCELLANEOUS
Section 801. This
Fourth Supplemental Indenture and the 2029 Notes shall be governed by and construed in accordance with the laws of the State of New York,
without regard to principles of conflicts of laws that would cause the application of laws of another jurisdiction. This Fourth Supplemental
Indenture is subject to the provisions of the Trust Indenture Act that are required to be part of the Indenture and shall, to the extent
applicable, be governed by such provisions.
8
Section 802. Except
as may be provided in a Future Supplemental Indenture, Article Six of the Base Indenture shall be amended by adding the following
Section 613:
“Section 613. Trustee’s
Cooperation.
So long as the outstanding
2029 Notes are registered in the name of Cede & Co. or its registered assigns, the Trustee shall cooperate with Cede &
Co., as sole registered owner, and its registered assigns in effecting payment of the principal of, Redemption Price and interest on the
2029 Notes by arranging for payment in such manner that funds for such payments are properly identified and are made immediately available
on the date they are due. The Company acknowledges that in order for the Trustee to make funds for such payments immediately available
to the Depository on the date they are due, the Company shall ensure the funds for such payments are remitted and made immediately available
to the Trustee, no later than 10:00 a.m. Eastern Time on the date they are due to Cede & Co. in order for the Trustee to
conform to the payment guidelines of the Depository. Funds for such payments received by the Trustee after 10:00 a.m. Eastern Time
on the date they are due to Cede & Co. may not be assured of timely payment and detail payment notification to the Depository
for subsequent allocation to the noteholders.”
Section 803. In
case any provision in this Fourth Supplemental Indenture or in the 2029 Notes shall be invalid, illegal or unenforceable, the validity,
legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.
Section 804. This
Fourth Supplemental Indenture may be executed in any number of counterparts, each of which shall be deemed to be an original, but all
such counterparts shall together constitute but one and the same Fourth Supplemental Indenture. The exchange of copies of this Fourth
Supplemental Indenture and of signature pages by facsimile, .pdf transmission, email or other electronic means shall constitute effective
execution and delivery of this Fourth Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile,
.pdf transmission, email or other electronic means shall be deemed to be their original signatures for all purposes. All notices, approvals,
consents, requests and any communications hereunder must be in writing (provided that any communication sent to the Trustee hereunder
must be in the form of a document that is signed manually or by way of a digital signature provided by DocuSign (or such other digital
signature provider as specified in writing to the Trustee by the authorized representative), in English. The Company agrees to assume
all risks arising out of the use of using digital signatures and electronic methods to submit communications to the Trustee, including
without limitation the risk of the Trustee acting on unauthorized instructions, and the risk of interception and misuse by third parties.
The Trustee shall have no liability for relying on such digital signatures or electronic methods.
Section 805. The
Base Indenture, as supplemented and amended by this Fourth Supplemental Indenture, is in all respects ratified and confirmed, and the
Base Indenture and this Fourth Supplemental Indenture shall be read, taken and construed as one and the same instrument with respect to
the 2029 Notes. All provisions included in this Fourth Supplemental Indenture supersede any conflicting provisions included in the Base
Indenture with respect to the 2029 Notes, unless not permitted by law. The Trustee accepts the trusts created by the Base Indenture, as
supplemented by this Fourth Supplemental Indenture, and agrees to perform the same upon the terms and conditions of the Base Indenture,
as supplemented by this Fourth Supplemental Indenture.
Section 806. The
provisions of this Fourth Supplemental Indenture shall become effective as of the date hereof.
Section 807. Notwithstanding
anything else to the contrary herein, the terms and provisions of this Fourth Supplemental Indenture shall apply only to the 2029 Notes
and shall not apply to any other series of Securities under the Base Indenture, and this Fourth Supplemental Indenture shall not and does
not otherwise affect, modify, alter, supplement or change the terms and provisions of any other series of Securities under the Base Indenture,
whether now or hereafter issued and Outstanding.
Section 808. The
recitals contained herein and in the 2029 Notes, except the Trustee’s certificate of authentication, shall be taken as the statements
of the Company, and the Trustee assumes no responsibility for their correctness. The Trustee makes no representations as to the validity
or sufficiency of this Fourth Supplemental Indenture, the 2029 Notes or any Additional Notes, except that the Trustee represents that
it is duly authorized to execute and deliver this Fourth Supplemental Indenture, authenticate the 2029 Notes and any Additional Notes
and perform its obligations hereunder. The Trustee shall not be accountable for the use or application by the Company of the 2029 Notes
or any Additional Notes or the proceeds thereof. All rights, protections, privileges, indemnities, immunities and benefits granted or
afforded to the Trustee under the Indenture shall be deemed incorporated herein by this reference and shall be deemed applicable to all
actions taken, suffered or omitted by the Trustee in each of its capacities hereunder.
9
IN WITNESS WHEREOF, the parties
hereto have caused this Fourth Supplemental Indenture to be duly executed as of the date first above written.
RUNWAY GROWTH FINANCE CORP.
By:
/s/ R. David Spreng
Name:
R. David Spreng
Title:
President and Chief Executive Officer
U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee
By:
/s/ Joshua A. Hahn
Name:
Joshua A. Hahn
Title:
Vice President
Exhibit A — Form of Global
Note
This Security is a Global Note within the meaning
of the Indenture hereinafter referred to and is registered in the name of The Depository Trust Company or a nominee thereof. This Security
may not be exchanged in whole or in part for a Security registered, and no transfer of this Security in whole or in part may be registered,
in the name of any Person other than The Depository Trust Company or a nominee thereof, except in the limited circumstances described
in the Indenture.
Unless this certificate is presented by an
authorized representative of The Depository Trust Company to the issuer or its agent for registration of transfer, exchange or payment
and such certificate issued in exchange for this certificate is registered in the name of Cede & Co., or such other name as requested
by an authorized representative of The Depository Trust Company, any transfer, pledge or other use hereof for value or otherwise by or
to any person is wrongful, as the registered owner hereof, Cede & Co., has an interest herein.
Runway Growth Finance Corp.
No.
$
CUSIP No. 78163D AB6
ISIN No. US78163DAB64
7.00% Notes due 2029
Runway Growth Finance Corp.,
a corporation duly organized and existing under the laws of Maryland (herein called the “Company”, which term includes any
successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede & Co., or registered
assigns, the principal sum of __________________________________ dollars (U.S. $_____________) on December 1, 2029, and to pay interest
thereon from May 29, 2026 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually
on June 1 and December 1 in each year, commencing December 1, 2026 (provided, that if an Interest Payment Date falls
on a day that is not a Business Day, then the applicable interest payment shall be made on the next succeeding Business Day and no additional
interest shall accrue as a result of such delayed payment), at the rate of 7.00% per annum, until the principal hereof is paid or made
available for payment. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date shall, as provided
in such Indenture, be paid to the Person in whose name this Security is registered at the close of business on the Regular Record Date
for such interest, which shall be May 15 or November 15 (whether or not a Business Day), as the case may be, next preceding
such Interest Payment Date. Any such interest not so punctually paid or duly provided for shall forthwith cease to be payable to the Holder
on such Regular Record Date and may either be paid to the Person in whose name this Security is registered at the close of business on
a Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders
of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner
not inconsistent with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such
notice as may be required by such exchange, all as more fully provided in said Indenture. This Security may be issued as part of a series.
Payment of the principal of
(and premium, if any) and any such interest on this Security shall be made at the Corporate Trust Office of the Trustee located at 111
Filmore Avenue, St. Paul, MN 55107, Attention: Runway Growth Finance Corp. (7.00% Notes Due 2029) in such coin or currency of the United
States of America as at the time of payment is legal tender for payment of public and private debts; provided, however,
that at the option of the Company payment of interest may be made by check mailed to the address of the Person entitled thereto as such
address shall appear in the Security Register; provided, further, however, that so long as the 2029 Notes are registered to Cede &
Co., such payment will be made by wire transfer in accordance with the procedures established by The Depository Trust Company and the
Trustee.
Reference is hereby made to
the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same
effect as if set forth at this place.
Unless the certificate of
authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature, this Security shall not
be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.
A-1
In
Witness Whereof, the Company has caused this instrument to be duly executed.
Dated:
RUNWAY GROWTH FINANCE CORP.
By:
Name: R. David Spreng
Title: Chief Executive Officer and President
Attest
By:
Name: Thomas B. Raterman
Title: Chief Operating Officer, Chief Financial Officer, Treasurer and Secretary
[Signature Page to Global Note]
A-2
This is one of the Securities
of the series designated therein referred to in the within-mentioned Indenture.
Dated:
U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,
as Trustee
By:
Name:
Title: Authorized Signatory
[Signature Page to Global Note]
A-3
Runway Growth Finance Corp.
7.00% Notes due 2029
This Security is one of a
duly authorized issue of Senior Securities of the Company (herein called the “Securities”), issued and to be issued in one
or more series under an Indenture, dated as of July 28, 2022 (herein called the “Base Indenture”), between the Company
and U.S. Bank Trust Company, National Association, as Trustee (herein called the “Trustee”, which term includes any successor
trustee under the Base Indenture), and reference is hereby made to the Base Indenture for a statement of the respective rights, limitations
of rights, duties and immunities thereunder of the Company, the Trustee, and the Holders of the Securities and of the terms upon which
the Securities are, and are to be, authenticated and delivered, as supplemented by the Fourth Supplemental Indenture, dated as of May 29,
2026, by and between the Company and the Trustee (herein called the “Fourth Supplemental Indenture”, the Fourth Supplemental
Indenture and the Base Indenture collectively are herein called the “Indenture”). In the event of any conflict between the
Base Indenture and the Fourth Supplemental Indenture, the Fourth Supplemental Indenture shall govern and control.
This Security is one of the
series designated on the face hereof, initially limited in aggregate principal amount to $____________. Under a Board Resolution, Officers’
Certificate pursuant to Board Resolutions or an indenture supplement, the Company may from time to time, without the consent of the Holders
of Securities, issue additional Securities of this series (in any such case “Additional Securities”) having the same ranking
and the same interest rate, maturity and other terms as the Securities. Any Additional Securities and the existing Securities will constitute
a single series under the Indenture and all references to the relevant Securities herein shall include the Additional Securities unless
the context otherwise requires. The aggregate amount of outstanding Securities represented hereby may from time to time be reduced or
increased, as appropriate, to reflect exchanges and redemptions.
Prior to the Par Call Date,
the Company may redeem the Securities at the Company’s option, in whole or in part, at any time or from time to time, at a Redemption
Price (expressed as a percentage of principal amount and rounded to three decimal points) equal to the greater of: (A)(1) the sum
of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming
the Securities matured on the Par Call Date) on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the
Treasury Rate plus 50 basis points less (2) interest accrued to the date of Redemption Date, and (B) 100% of the principal amount
of the Securities to be redeemed, plus, in either case, accrued and unpaid interest, if any, to but excluding, the Redemption Date.
Notwithstanding the foregoing,
on or after the Par Call Date, the Company may redeem the Securities, in whole or in part, at any time and from time to time, at a Redemption
Price equal to 100% of the principal amount of the Securities to be redeemed plus accrued and unpaid interest thereon to the Redemption
Date.
“Par Call Date”
means June 1, 2029.
“Treasury Rate”
means, with respect to any Redemption Date of the 2029 Notes, the yield determined by the Company in accordance with the following two
paragraphs.
The Treasury Rate shall be
determined by the Company after 4:15 p.m., New York City time (on or after such time as yields on U.S. government securities are posted
daily by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the Redemption Date based upon the
yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published by the
Board of Governors of the Federal Reserve System designated as “Selected Interest Rates (Daily)-H.15” (or any successor designation
or publication) (“H.15”) under the caption “U.S. government securities-Treasury constant maturities -Nominal”
(or any successor caption or heading) (“H.15 TCM”). In determining the Treasury Rate, the Company shall select, as applicable:
(1) the yield for the Treasury constant maturity on H.15 exactly equal to the period from the Redemption Date to the Par Call Date
(the “Remaining Life”); or (2) if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining
Life, the two yields - one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding
to the Treasury constant maturity on H.15 immediately longer than the Remaining Life - and shall interpolate to the Par Call Date on a
straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or (3) if
there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury
constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity or
maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury
constant maturity from the Redemption Date.
A-4
If on the third Business Day
preceding the Redemption Date H.15 TCM is no longer published, the Company shall calculate the Treasury Rate based on the rate per annum
equal to the semiannual equivalent yield to maturity at 11:00 a.m., New York City time, on the second Business Day preceding such Redemption
Date of the United States Treasury security maturing on, or with a maturity that is closest to, the Par Call Date, as applicable. If there
is no United States Treasury security maturing on the Par Call Date but there are two or more United States Treasury securities with a
maturity date equally distant from the Par Call Date, one with a maturity date preceding the Par Call Date and one with a maturity date
following the Par Call Date, the Company shall select the United States Treasury security with a maturity date preceding the Par Call
Date. If there are two or more United States Treasury securities maturing on the Par Call Date or two or more United States Treasury securities
meeting the criteria of the preceding sentence, the Company shall select from among these two or more United States Treasury securities
the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United
States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury Rate in accordance with the terms of this paragraph,
the semiannual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked
prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and
rounded to three decimal places.
The Company’s actions
and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error. For the
avoidance of doubt, the Trustee shall have no duty to calculate the redemption price, nor shall it have any duty to review or verify the
Company’s calculations of the redemption price.
Notice of redemption shall
be given in writing and mailed, first-class postage prepaid, by overnight courier guaranteeing next-day delivery or sent electronically
in accordance with the applicable procedures of DTC with respect to 2029 Notes in global form, to each Holder of the Securities to be
redeemed, not less than thirty (30) nor more than sixty (60) days prior to the Redemption Date, at the Holder’s address,
facsimile or email address appearing in the Security Register. All notices of redemption shall contain the information set forth in Section 1104
of the Base Indenture.
Any exercise of the Company’s
option to redeem the Securities shall be done in compliance with the Investment Company Act, and the rules, regulations and interpretations
promulgated thereunder, to the extent applicable.
If the Company elects to redeem
only a portion of the Securities, the particular Securities to be redeemed will be selected by the Trustee in accordance with the applicable
procedures of the Depositary and in accordance with Section 1103 of the Base Indenture and the Investment Company Act, and the rules and
regulations promulgated thereunder, to the extent applicable. In the event of redemption of this Security in part only, a new Security
or Securities of this series and of like tenor for the unredeemed portion hereof shall be issued in the name of the Holder hereof upon
the cancellation hereof.
Unless the Company defaults
in payment of the Redemption Price, on and after the Redemption Date, interest shall cease to accrue on the Securities called for redemption.
Holders will have the right
to require the Company to repurchase their Securities upon the occurrence of a Change of Control Repurchase Event as set forth in the
Indenture.
The Indenture contains provisions
for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect
to this Security, in each case upon compliance with certain conditions set forth in the Indenture.
If an Event of Default with
respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due
and payable in the manner and with the effect provided in the Indenture.
A-5
The Indenture permits, with
certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the
rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with
the consent of the Holders of not less than a majority in principal amount of the Securities at the time Outstanding of each series to
be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities
of each series at the time Outstanding, on behalf of the Holders of all Securities of such series, to waive compliance by the Company
with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver
by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any
Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent
or waiver is made upon this Security.
As provided in and subject
to the provisions of the Indenture, the Holder of this Security shall not have the right to institute any proceeding with respect to the
Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously
given the Trustee written notice of a continuing Event of Default, other than an Event of Default referred to in Section 501(5) or
Section 501(6) of the Indenture with respect to the Company, with respect to the Securities of this series, the Holders of not
less than 25% in principal amount of the Securities of this series at the time Outstanding shall have made written request to the Trustee
to institute proceedings in respect of such Event of Default as Trustee and offered the Trustee indemnity and/or security against the
costs, expenses and liabilities to be incurred in compliance with such request, and the Trustee shall not have received from the Holders
of a majority in principal amount of Securities of this series at the time Outstanding a direction inconsistent with such request, and
shall have failed to institute any such proceeding, for sixty (60) days after receipt of such notice, request and offer of indemnity
and/or security. The foregoing shall not apply to any suit instituted by the Holder of this Security for the enforcement of any payment
of principal hereof or any premium or interest hereon on or after the respective due dates expressed herein. If an Event of Default referred
to in Section 501(5) or Section 501(6) of the Indenture with respect to the Company has occurred, the entire principal
amount of all the Securities of this series shall automatically become due and immediately payable.
No reference herein to the
Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the Company, which is absolute
and unconditional, to pay the principal of and any premium and interest on this Security at the times, place and rate, and in the coin
or currency, herein prescribed.
As provided in the Indenture
and subject to certain limitations therein set forth, the transfer of this Security is registrable in the Security Register, upon surrender
of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and any premium
and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to
the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one
or more new Securities of this series and of like tenor, of authorized denominations and for the same aggregate principal amount, will
be issued to the designated transferee or transferees.
The Securities of this series
are issuable only in registered form without coupons in minimum denominations of $2,000 and any integral multiples of $1,000 in excess
thereof. As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable
for a like aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested
by the Holder surrendering the same.
No service charge shall be
made for any such registration of transfer or exchange, but the Company or Trustee may require payment of a sum sufficient to cover any
tax or other governmental charge payable in connection therewith.
Prior to due presentment of
this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person
in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue, and neither the
Company, the Trustee nor any such agent shall be affected by notice to the contrary.
A-6
All terms used in this Security
which are defined in the Indenture shall have the meanings assigned to them in the Indenture.
The Indenture and this Security
shall be governed by and construed in accordance with the laws of the State of New York, without regard to principles of conflicts of
laws.
A-7
EX-5.1 — EXHIBIT 5.1
EX-5.1
Filename: tm2616014d1_ex5-1.htm · Sequence: 4
Exhibit 5.1
1900 K Street, NW
Washington, DC 20006-1110
+1 202 261 3300 Main
+1 202 261 3333 Fax
www.dechert.com
May 29, 2026
Runway Growth Finance Corp.
205 N. Michigan Ave., Suite 4200
Chicago, Illinois 60601
Re: Registration
Statement on Form N-2
Ladies and Gentlemen:
We have acted as counsel to Runway Growth Finance
Corp., a Maryland corporation (the “Company”), in connection with the public offering of $50,000,000 in aggregate
principal amount of the Company’s 7.00% unsecured notes due 2029 (the “Notes”), pursuant to the Company’s
registration statement on Form N-2 (File No. 333-284781) (as amended as of the date hereof, the “Registration Statement”)
filed with the U.S. Securities and Exchange Commission (the “Commission”) and previously declared effective by the
Commission on March 19, 2025, relating to the public offering of securities of the Company that may be offered by the Company from
time to time as set forth in the prospectus dated March 19, 2025, which was included in the Registration Statement and forms a part
of the Registration Statement (the “Prospectus”), and as may be set forth from time to time in amounts, at prices,
and on terms to be set forth in one or more supplements to the Prospectus. This opinion letter is rendered in connection with such public
offering of the Notes, as described in the prospectus supplement dated May 27, 2026 (the “Prospectus Supplement”),
filed with the Commission pursuant to Rule 424 under the Securities Act of 1933, as amended (the “Securities Act”).
All of the Notes are to be sold by the Company as described in the Registration Statement and related Prospectus and Prospectus Supplement.
This opinion letter is being furnished to the Company in accordance with the requirements of Item 25 of Form N-2 under the Securities
Act, and no opinion is expressed herein as to any matter other than as to the legality of the Indenture (as defined below) and the Notes.
The Notes have been issued pursuant to the indenture
dated as of July 28, 2022 (the “Base Indenture”), between the Company and U.S. Bank, National Association, as
trustee (the “Trustee”), as supplemented by the Fourth Supplemental Indenture, dated as of May 29, 2026 (together
with the Base Indenture, the “Indenture”), between the Company and the Trustee.
May 29, 2026
Page 2
In rendering the opinions expressed below, we
have examined and relied on originals or copies, certified or otherwise identified to our satisfaction, of such documents, corporate
records and other instruments and such agreements, certificates and receipts of public officials, certificates of officers or other representatives
of the Company and others, and such other documents as we have deemed necessary or appropriate as a basis for rendering this opinion,
including the following documents:
(i) the Registration Statement;
(ii) the Underwriting Agreement;
(iii) the Indenture;
(iv) a specimen copy of the form of the Notes
to be issued pursuant to the Indenture;
(v) the Articles of Amendment and Restatement
and the Articles of Amendment of the Company;
(vi) the Second Amended and Restated Bylaws
of the Company;
(vii) a certificate of good standing with
respect to the Company issued by the State Department of Assessments and Taxation of the
State of Maryland as of a recent date; and
(viii) resolutions of the board of directors
of the Company relating to, among other things, the authorization and issuance of the Notes.
As to the facts upon which this opinion letter
is based, we have relied, to the extent we deem proper, upon certificates of public officials and certificates, written statements and
oral representations of officers, directors, employees and representatives of the Company without having independently verified such
factual matters.
In our examination, we have assumed the genuineness
of all signatures, the authenticity of all documents submitted to us as original documents and the conformity to original documents of
all documents submitted to us as copies. In addition, we have assumed (i) the legal capacity of natural persons and (ii) the
legal power and authority of all persons signing on behalf of the parties to all documents (other than the Company).
On the basis of the foregoing, such examination
of law as we have deemed necessary, and subject to the assumptions and qualifications set forth in this letter, we are of the opinion
that:
1. The
Indenture has been duly authorized, executed and delivered by the Company and constitutes the valid and legally binding obligation of
the Company, enforceable against the Company in accordance with its terms.
May 29, 2026
Page 3
2. Assuming
the Notes have been duly authenticated by the Trustee in accordance with the terms of the Indenture, the Notes constitute valid and legally
binding obligations of the Company, enforceable against the Company in accordance with their terms.
The opinions set forth herein are subject to
the following assumptions and qualifications being true and correct at or before the issuance of the Notes:
(i) the Indenture and the Notes have been
duly authorized, executed and delivered by each party thereto (other than the Company); and
(ii) the terms of the Notes as established
comply with the applicable requirements of the Investment Company Act of 1940, as amended.
The opinions set forth herein as to enforceability
of obligations of the Company are subject to: (i) bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or similar
laws now or hereinafter in effect affecting the enforcement of creditors’ rights generally, and by general principles of equity
(regardless of whether enforcement is sought in a proceeding in equity or at law) and the discretion of the court or other body before
which any proceeding may be brought; (ii) the unenforceability under certain circumstances under law or court decisions of provisions
providing for the indemnification of, or contribution to, a party with respect to a liability where such indemnification or contribution
is contrary to public policy; (iii) an implied covenant of good faith and fair dealing; (iv) provisions of law which may require
that a judgment for money damages rendered by a court in the United States be expressed only in U.S. dollars; (v) requirements that
a claim with respect to any debt securities denominated other than in U.S. dollars (or a judgment denominated other than in U.S. dollars
in respect of such claim) be converted into U.S. dollars at a rate of exchange prevailing on a date determined pursuant to applicable
law; and (iv) governmental authority to limit, delay or prohibit the making of payments outside the United States or in foreign
currency or composite currency.
We express no opinion as to the validity, legally
binding effect or enforceability of any provision in any agreement or instrument that (i) requires or relates to payment of any
interest at a rate or in an amount which a court may determine in the circumstances under applicable law to be commercially unreasonable
or a penalty or forfeiture or (ii) relates to governing law and submission by the parties to the jurisdiction of one or more particular
courts.
The opinions expressed herein are limited to
the federal laws of the United States of America, the laws of the State of New York and the Maryland General Corporation Law. We are
members of the bar of the State of New York.
May 29, 2026
Page 4
We assume no obligation to advise you of any
changes in the foregoing subsequent to the date of this opinion.
We hereby consent to the filing of this opinion
as an exhibit to the Company’s Current Report on Form 8-K, dated May 29, 2026 and to the reference to this firm under
the caption “Legal Matters” in the Prospectus Supplement which forms a part of the Registration Statement. In giving such
consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities
Act or the rules and regulations of the Commission thereunder.
Very truly yours,
/s/ Dechert LLP
GRAPHIC
GRAPHIC
Filename: tm2616014d1_ex5-1img001.jpg · Sequence: 9
Binary file (4338 bytes)
Download tm2616014d1_ex5-1img001.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 11
v3.26.1
Cover
May 27, 2026
Document Type
8-K
Amendment Flag
false
Document Period End Date
May 27, 2026
Entity File Number
814-01180
Entity Registrant Name
Runway Growth Finance Corp.
Entity Central Index Key
0001653384
Entity Tax Identification Number
47-5049745
Entity Incorporation, State or Country Code
MD
Entity Address, Address Line One
205 N. Michigan Ave.
Entity Address, Address Line Two
Suite 4200
Entity Address, City or Town
Chicago
Entity Address, State or Province
IL
Entity Address, Postal Zip Code
60601
City Area Code
312
Local Phone Number
698-6902
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Entity Emerging Growth Company
true
Elected Not To Use the Extended Transition Period
false
Common Stock Par Value 0. 01 Per Share [Member]
Title of 12(b) Security
Common Stock, par value $0.01 per share
Trading Symbol
RWAY
Security Exchange Name
NASDAQ
Sec 7. 50 Notes Due 2027 [Member]
Title of 12(b) Security
7.50% Notes due 2027
Trading Symbol
RWAYL
Security Exchange Name
NASDAQ
Notes 7. 25 Due 2031 [Member]
Title of 12(b) Security
7.25% Notes due 2031
Trading Symbol
RWAYI
Security Exchange Name
NASDAQ
Notes 9. 00 Due 2027 [Member]
Title of 12(b) Security
9.00% Notes due 2027
Trading Symbol
SWKHL
Security Exchange Name
NASDAQ
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 7A
-Section B
-Subsection 2
+ Details
Name:
dei_EntityExTransitionPeriod
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=rway_CommonStockParValue0.01PerShareMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=rway_Sec7.50NotesDue2027Member
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=rway_Notes7.25Due2031Member
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=rway_Notes9.00Due2027Member
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type: